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While information regarding the impact of flavan-3-ol-protein interactions on 
food quality attributes (flavor, texture, and physical stability) exists, insight into the 
potential consequence of these interactions on bioavailability of health-promoting flavan-
3-ols remains unclear.  The ability of nonspecific protein interactions in flavan-3-ol rich 
foods and beverages to alter digestive stability and/or digestive release (bioaccessibility) 
of flavan-3-ols has been previously proposed but unconfirmed.  The primary objective of 
this study was to characterize effects of individual milk proteins and the milk matrix on 
in vitro bioaccessibility of green tea flavan-3-ols from model beverage systems.  As a 
secondary objective, the impact of protein gastrointestinal digestion on protein-flavan-3-
ol binding was assessed using fluorometry. Protein solutions containing sodium-caseinate 
(S-CSN), α-lactalbumin (α-LA), β-lactoglobulin (β-LG) (0.356  mg/100 mL, 0.01 mg/100 
mL, 0.035 mg/100 mL, respectively), or non-fat dry milk (NFDM, 0.1 mg/mL)  were 
prepared in Jenness Koops buffer containing milk salts or dd water and formulated at 
dosages of 10, 20, and 40% (v/v) into model green tea beverages containing 60 mg/100 





human gastric and small intestinal conditions. Pre- and post-digestion flavan-3-ol profiles 
were assessed by HPLC and relative (%) and absolute (μmol/g) bioaccessibility of 
individual flavan-3-ols were calculated. With regards to green tea beverages formulated 
to 40% with milk protein solutions, inclusion of S-CSN significantly decreased (p<0.05) 
bioaccessibility of all flavan-3-ols, β-LG significantly decreased (p<0.05) bioaccessibility 
of all flavan-3-ols except EGC, and α-LA significantly decreased (p<0.05) 
bioaccessibility of only gallated catechins compared to buffer controls. Furthermore, S-
CSN effects on flavan-3-ol absolute bioaccessibility were more notable compared to 
whey proteins, decreasing bioaccessibility of EGC, EC, EGCG, and ECG from 
98.29±9.22, 30.88±0.52, 40.52±1.16, and 6.51±0.16 μmol/g, respectively, from JK buffer 
control to 17.82±4.68, 21.72±1.23, 11.29±1.18, and 2.86±1.20 μmol/g, respectively. 
Interestingly, milk minerals from JK buffer increased flavan-3-ol stability during 
digestion compared to water control, significantly increasing (p<0.05) absolute and, by 
extension, relative bioaccessibility from 18 to 32%.While some individual trends were 
exhibited, no overall significant dose-dependent effects (p>0.05) were observed at protein 
and JK levels tested. SDS-PAGE results demonstrated only partial digestion of protein 
after peptic digestion, and degradation of proteins to <10 kDa after only 15 minutes of 
duodenal digestion. These results compared well with fluorometry results suggesting that 
maximum binding of S-CSN by EGCG, the main flavan-3-ol in green tea, occurs when 
protein is partially digested by pepsin in the gastric phase.  Further digestion by 
pancreatin in the small intestinal phase appeared to reduce capacity for binding.  
Combined these data suggest that interactions between individual milk proteins and 





dependent on the ability of individual interactions to survive normal digestive conditions.  
Interestingly, salts typically found in milk serum may exert protective effects on 
polyphenols from tea, stabilizing them to digestive reactions that may lead to their 











CHAPTER 1. LITERATURE REVIEW 
1.1 Introduction 
Both epidemiological and experimental studies support the notion that specific 
plant derived polyphenols may impact chronic disease risk and health outcomes (Scalbert 
& Williamson, 2000).  While promising, extension of these findings to new food and 
beverage systems is challenged by the poor bioavailability of polyphenols generally 
reported from foods.  Several factors are believed to limit polyphenol bioavailability 
including digestive release from food matrices (Mandalari et al. 2013), instability to 
digestive conditions (Krook et al. 2012; Bermúdez-Soto et al. 2007; Green et al., 2007; 
Tagliazucchi et al. 2010), poor intestinal absorption, and rapid metabolism and clearance 
(Chow et al. 2005; Lee et al. 2002).  Interactions between polyphenols and specific food 
components are also believed to alter stability and release of polyphenols and potentially 
modulate their bioavailability (Peters et al. 2010; Green et al. 2007; Nielson et al. 2009; 
Mandalari et al. 2013; Sanz & Luyten 2006). Of many potential interactions occurring in 
foods, the ability of polyphenols to bind to protein and facilitate their denaturation and 
precipitation has been subject of intensive investigation (Batista et al. 2009; Bohin et al. 
2012; De Freitas & Mateus 2001; Pascal et al. 2007; Poncet-Legrand, 2007; Sharma et al. 
2008; Soares et al. 2007; Staszewski et al. 2011; Wang et al. 2010; Yuksel et al. 2010). 





polyphenol rich foods (Siebert et al. 2011; Kennedy et al. 2006; Vidal et al. 2004; 
Misnawi et al. 2004; Troszyńska et al. 2006), these interactions are believed to alter both 
polyphenol and protein stability in foods and beverages, thereby affecting their 
availability for chemical reactivity, subsequent digestive release/stability in the gut 
(bioaccessibility) and potential for intestinal absorption and metabolism by the body 
(bioavailability) (Arts et al. 2002; López de Lacey et al. 2012; Naz et al. 2011; Niseteo et 
al. 2012; Serafini et al. 2003; Sharma et al. 2008).     
When considering prevalence for protein-polyphenol interactions, several common  
foods/beverage systems have been studied including beer and wine hazing (Gramshaw et 
al. 1970; Goertges 1982; Kallithraka et al. 2011; Rinaldi 2012), grain tannins 
(Emmambux & Taylor 2003; Amarowicz et al. 2005; Mullins & Lee 1991) and milk co-
formulated with cocoa and tea (Xie et al. 2012; Green et al. 2007; van der Burg-
Koorevaar et al. 2011; Reddy et al. 2005; van het Hof et al. 1998; Hollman et al. 2001; 
Kyle et al. 2007; Keogh et al. 2007; Roura et al. 2007; Schramm et al. 2003; Serafini et al. 
2003; Neilson et al. 2009).  Of these foods, tea remains one of the most significant 
dietary sources of polyphenols in the US diet (Song et al. 2008; Wang et al. 2011; Chun 
et al. 2007) and its consumption has been associated with prevention and/or amelioration 
of several chronic and degenerative diseases including cancer (Yuan et al. 2007; Hung et 
al. 2004; Bonner et al. 2005), cardiovascular disease (Hooper et al. 2008; Zuchi et al. 
2010; Steptoe et al. 2007), diabetes (van Dieren et al. 2009; Song et al. 2005) and 
neurodegenerative processes (Kuriyama et al. 2006; Ng et al. 2008; Hu et al. 2007). Tea 
is a rich source of flavan-3-ols or catechins, specifically epicatechin (EC), 





Interestingly, tea is also commonly consumed with addition of protein rich milk in 
Ireland, Canada, and the UK (Devine et al. 2007; Yang et al. 2000; Weisburger et al. 
1997; Hertog et al.1997) and increasingly in other countries including the US.  Several 
studies have demonstrated the ability of flavan-3-ols to interact with individual milk 
proteins, with these interactions having potential to alter their biological activities (Arts et 
al. 2002; Lorenz et al. 2007) and bioavailability (Shpigelman et al. 2012). Hydrophobic 
interactions between bovine milk proteins and polyphenols occur (Yuksel et al. 2010) 
that are structurally specific and increase with galloylation (i.e. stronger for EGCG and 
ECG than for EC and EGC) (Xiao et al. 2011).  
Effect of milk addition to tea flavan-3-ol bioaccessibility and bioavailability has been 
previously explored both in vivo and in vitro, however results to date have been 
inconsistent and remain controversial. For example, addition of milk at 5.6-40% had no 
affect on black tea flavan-3-ol bioaccessibility (van der Burg-Koorevaar et al. 2011), 
however others have demonstrated that addition of milk between 10 and 50% impact 
flavan-3-ol bioaccessibility from black and green tea in vitro (Xie et al. 2012; Green et al. 
2007).  However, addition of milk to black tea had no apparent affect on levels of blood 
flavan-3-ol in vivo (Van het Hof et al.1998; Kyle et al. 2007). While interactions between 
flavan-3-ols and protein are well documented, it is unclear the extent to which these 
polyphenol-protein interactions may impact availability of flavan-3-ols for reaction and 
absorption in the gut. Furthermore, information on the effect of specific milk proteins on 
digestive release and stability in the gastrointestinal tract is lacking.  Additional insight is 





associations between individual milk proteins with flavan-3-ols in order to leverage 
potential effects for optimal delivery of dietary polyphenols. 
The overall objective of this thesis is to develop a more detailed understanding of 
how interaction between select green tea flavan-3-ols and milk proteins can alter their 
bioaccessibility from model beverage systems. The purpose of this literature review is to 
characterize predominant flavan-3-ol components present in green tea, review their 
associated health benefits and summarize the current state of understanding relative to 
their bioavailability, metabolism and biological activity as influenced by protein.  
 
1.2 Classification and Nomenclature of Polyphenol Compounds 
Polyphenols are plant metabolites synthesized through the shikimate and acetate 
pathways (Strack D. 1997).  Characterized as secondary metabolites, polyphenols aid in 
plant growth and reproduction as well as serve to protect the plant from pathogens and 
predators. In addition, many classes of polyphenols also serve as substrates for 
enzymatically driven browning reactions and can function as antioxidants in plants 







Figure 1: Major phenolic classes of plant secondary metabolites. 
 
Over 8,000 phenolic compounds have been documented in nature (Tsao R. 2010). 
The four main classes of polyphenols include phenolic acids, flavonoids, stilbenes, and 
lignans (Scalbert et al. 2000) (Figure 1). Phenolic rings containing one or more hydroxyl 
substituents are characteristic of most phenolic structures. Simple phenolic acids can be 
divided into two main types, benzoic acid and cinnamic acid derivatives, based on C1–C6 
and C3–C6 backbones. Two major phenolic acids are caffeic acid, found in fruits, 
vegetables and coffee, and ferulic acid, typically found in the bran fraction of cereal grain 
(Scalbert et al. 2000). Flavonoids are more complex polyphenols having a C6–C3–C6 
backbone in which the two C6 units are of phenolic nature (Tsao R. 2010). Flavonoids 
can be further divided into different sub-groups according to the oxidation state of the 
heterocyclan pyran ring (Cheynier 2005). Major flavonoid classes include anthocyanins, 
















































Flavan-3-ols are believed to be the most abundant flavonoid found in the western diet 
(Chun et al. 2007).  They are present in numerous common foods and beverages 
including tea, apple, cocoa and grape derived products (Hara et al. 1995; Gu et al. 2004) 
(Table 1). Flavan-3-ols are structurally characterized by a lack in each a double bond 
between C2 and C3, a C4 carbonyl, and of conjugation to glycosidic moiety at C3 (as 
most other classes of flavonoids naturally are). These unique structural characteristics 
provide flavan-3-ols the ability to have two chiral centers and four diasteroisomers (Tsao 
2010). Furthermore, monomeric catechin and epi-catechin are known to  be precursours 
for more complicated polymers referred to as proanthocyanidins (PACs) ranging in 
degree of polymerization from DP2 to about DP30 (Takahata et al. 2001; Hayasaka et al. 
2003; Hanlin et al. 2011). The eight major flavan-3-ol monomers that occur in nature and 
predominate in green tea include (-)-gallocatechin-3-gallate (GCG), (-)-epigallocatechin-
3-gallate (EGCG), (-)-gallocatechin (GC), (-)-epigallocatechin (EGC), (+/-)-catechin (C), 
(-)-epicatechin (EC), (-)-catechin-3-gallate (CG) and (-)-epicatechin-3-gallate (ECG). 
The 5’ position on the B ring of EGC is a pyrogallol group, compared to the pyrocatechol 
group on the same position of EC. ECG and EGCG are gallic esters of EC and EGC, 






Table 1: Flavonoid content of selected foods. 
Adapted from: U.S. Department of Agriculture, Agricultural Research Service. 2011. USDA. Database for the Flavonoid Content of Selected Food. 
Food Number of 
data points 
Mean concentration (mg/100g, edible portion) +/- SEM 
(-) –EC (-) -ECG (-) -EGC (-) -EGCG (+) -C (+) -GC Total 




9.29 ± 0.46 












5.96 ± 2.35 












6.10 ± 5.45 












261.25 ± 47.65 












108.60 ± 14.71 












15.04 ± 2.94 










21.63 ± 3.82 
Grape juice 25 – 28 0.54 ± 0.07 
     
-  
 




1.33 ± 0.11 
Grapes, white or green 7 or 14 1.70 ± 0.42 0.25 ± 0.08 0.02 ± 0.00   -  
 
3.73 ± 0.92 0.01 ± 0.00 5.71 ± 1.01 
Tea, black, brewed 55 – 94 2.13 ± 0.10 5.86 ± 0.17 8.07 ± 0.45 9.36 ± 0.46 1.51 ± 0.07 1.25 ± 0.22 28.18 ± 0.71 
Tea, green, brewed 66 - 97  7.36 ± 0.31 16.39 ± 1.93 22.27 ± 0.89 64.15 ± 5.02 3.28 ± 0.88 1.54 ± - 114.99 ± 5.53 
Tea, green, ready-to-drink 2 1.98 ± 0.11 0.93 ± 0.06 4.99 ± 0.53 3.96 ± 0.40 0.02 
    
11.88 ± 0.68 








 -  
 






1.3 Polyphenol Biosynthesis 
Phenylalanine, a product of the shikimate pathway is a precursor for the majority of 
phenolic compounds found in plants.  The biosynthesis of polyphenolic compounds is 
outlined in Figure 3. General polyphenol metabolism involves conversion of 
phenylalanine to p-coumaric acid (hydroxycinnamic acid). Key enzymes catalyzing this 
transformation include phenylalanine ammonialyase (PAL), cinnamate 4-hydroxylase 
(C4H), and hydroxycinnamate CoA ligase (CoAL). PAL catalyzes deamination of 
phenylalanine to trans-cinnamic acid followed by hydroxylation and methylation 
reactions catalyzed by monooxygenases to form hydroxycinnamates. 
Hydroxycinnamate:CoA ligase or O-glucosyltransferase then activate hydroxycinnamates. 
Resulting hydroxycinnamate CoAs enter phenylpropanoid reactions including: 
condensation with malonyl-CoA leading to flavonoids; degradation by removal of an 
acetate unit resulting in hydroxybenzoates; NADPH-dependent reduction leading to 
lignin precursors and hydroxycinnamyl alchohols; and conjugation through attachment to 
a hydroxyl or amino-group-bearing molecule with loss of water leading to esters, amides, 
or in rare cases attachment to phenolic hydroxyl groups leading to glycosides (Strack D. 
1997).  
Flavonoid biosynthesis is initiated by chalcone synthase, which synthesizes the basic 
C15 skeleton by catalyzing condensation of 4-coumaroyl-CoA to form 2’,4,4’,6’-
tetrahydroxychalcone. Naringenin chalcone, possessing the characteristic B-ring of 
flavonoids, is the first intermediate product. Acetyl-CoA carboxylase supplies Malonyl-
CoA providing acetate units that randomly orient to form the flavonoid A-ring, leading 





commonly 3-O-(di)glycosides (Strack D. 1997). Exceptions include some 





































































Ashihara et al. 2010 suggested possible biosynthetic pathways of specific flavan-3-
ols. Chalcone isomerase transforms naringenin-chalcone into naringenin, which is then 
converted to dihydrokaempferol (DHK) by flavanone 3-hydroxylase. From here there are 
two pathways that may occur: one resulting in EGC and EGCG, and the other in EC and 
ECG. DHK is converted to either dihydromyricetin or dihydroquercetin by flavonoid 
3’,5’-hydroxylase or flavanone 3-hydroxylase, respectively, followed by sequential 
enzymatic transformations by dihydroflavanol 4-reductase (DFR), anthocyaninin 
synthase (ANS), and anthocyanidin reductase (ANR). EGC results from enzymatic 
transformation of dihydromyricetin, and EC from dihydroquercetin. EGC and EC may 
then become esterified to gallic acid at the C3 position to form EGCG and ECG, 
respectively.  
 
1.4 Flavan-3-ols and Health 
1.4.1 Cardiovascular Disease 
Cardiovascular diseases (CVDs) are major contributors to fatality worldwide. 
Major causes of CVDs are believed to include oxidized low density lipoprotein (LDL) 
and free radical damage to the endothelium which ultimately results in inflammatory 
stress and subsequent damage to endothelial structure.  Stiffness and blockages may then 
develop in vessels leading to increased risk for heart attacks, stroke or other forms of 
coronary artery disease (Mendis et al. 2011).  
Many studies have suggested a protective association between dietary polyphenol 
consumption and CVD risk and outcomes. Intermediate intake (mg/day) of flavonoid 





proanthocyanidins were associated with a lower risk of death from CVD (McCullough et 
al. 2012). Furthermore, meta-analysis of randomized controlled trials indicated isoflavone 
and flavan-3-ol rich foods specifically including chocolate, soy protein isolate, and green 
tea significantly reduce cardiovascular risk factors (Hooper et al. 2008) and 
supplementation of 200 mg/day of grape seed flavan-3-ols resulted in a significant 
improvement in overall vascular health (Weseler et al. 2011). In addition, lag time in 
LDL oxidation ex vivo significantly increased in healthy men consuming an equivalent of 
seven to eight cups a day of green tea for two weeks (Miura et al. 2000), however 
consumption of six cups of green or black tea per day for four weeks showed no effect on 
LDL oxidation in vivo or ex vivo (van het Hof et al. 1997), indicating that tea flavonoids 
may have more of an effect on onset than extent of LDL oxidation. 
Risk of heart attack is increased by adherence and aggregation of blood platelets 
to the vascular wall (Gregg & Goldschmidt-Clermont 2003). Studies suggest that flavan-
3-ol-rich supplements and select flavonoid rich foods may decrease platelet aggregation. 
Consumption of flavan-3-ol rich dark chocolate (40 g) by heart transplant recipients 
decreased platelet adhesion in correlation to increased serum epicatechin, and improved 
coronary vasomotion (Flammer et al. 2007). In addition, ADP- and epinephrine- 
stimulated platelet activity of plasma from male smokers was decreased ex vivo following 
consumption of a flavan-3-ol-rich supplement (Polagruto et al. 2007). 
 
1.4.2 Cancer 
Cancer is caused by uncontrolled growth and spread of abnormal cells that often 





about $226.8 billion and in 2008, about 12 million Americans had a history of cancer.  
(American Cancer Society 2012). 
Results from epidemiological studies concerning effect of flavan-3-ols on cancer 
have been inconclusive for the most part.  Flavan-3-ol rich green tea has been both 
negatively associated (Wang et al. 2007; Hung et al. 2004) and unassociated (Wang et al. 
2002) with esophageal cancer and associated both negatively (Zhong et al. 2001; Bonner 
et al. 2005) and positively (Tewes et al. 1990) with lung cancer risk. Furthermore, in the 
Shanghai Cohort Study EGC and its methylated metabolite, but not EC nor its 
metabolites, were significantly associated with colon cancer protection in men (Yuan et 
al. 2007). Confounding variables such as temperature of the tea and smoking status of 
participants may complicate analysis of data in esophageal and lung cancer studies, 
respectively (Gao et al. 1994; Yuan et al. 2011).  
 
1.4.3 Diabetes 
Diabetes is the 7th leading cause of death in the United States, affecting about 8.3% 
of the population (Centers for Disease Control and Prevention 2011). The metabolic 
disorder is characterized by hyperglycemia due to defects in insulin secretion and/or 
action (American Diabetes Association2008). 
Similar to studies on association of flavan-3-ol effects with cancer, studies 
exploring effect of flavan-3-ol consumption on diabetes have been inconclusive. Coffee 
and tea consumption (3 cups/day) reduced risk of type 2 diabetes by about 42% in one 





between diabetes risk and consumption of coffee or tea, except in subjects over 60 years 
old who had lost weight (Greenberg et al. 2005).  
 
1.4.4 Neuroprotection 
Cognitive deterioration during the ageing process is a major concern. Two major 
diseases characterized by cognitive decline are Alzheimer’s disease (AD) and 
Parkinson’s disease (PD). One in eight Americans suffer from AD, an ailment caused by 
accumulation of amyloid peptides and tau protein in brain neurons (Alzheimer’s 
Association 2012). PD is a neurodegenerative disease caused by dysfunction of 
dopaminergic neurons (Schapira et al. 1990; Parker et al. 2008; Keeney et al. 2006) and 
affects about 1 in 100 people (Shapira 2004). Longitudinal and cross-sectional studies 
found that total tea intake by Chinese, Japanese, and Finnish adults was significantly 
associated with lower prevalence of cognitive decline (Ng et al. 2008; Kuriyama et al. 
2006; Hu et al. 2007).  
Evidence from numerous animal studies further supports that flavan-3-ols may 
have neuroprotective benefits. EGCG (50 mg/kg) administered orally through drinking 
water for 6 months reduced amyloid β peptides and modulated tau profiles in Alzheimer 
transgenic mice (Rezai-Zadeh et al. 2008). The ability of green tea polyphenols (GTPs) to 
improve stress induced cognitive impairment was studied. Male Sprague–Dawley rats 
consuming ≥0.5% GTPs in their diet showed improved psychological stress-induced 
cognitive function compared to controls (Chen et al. 2009). Furthermore, GTPs (150 and 





oxygen species and nitric oxide, and inhibited lipid peroxidation in Male Sprague–
Dawley rat models of PD (Guo et al. 2007). 
It is important to note that results presented above have been inconsistent.  
Variability in food, food component and polyphenol doses (low to high supplemental 
doses) between studies may contribute to these observations.  Each type of study has 
potential drawbacks. In epidemiological studies, correlations, but not causation, can be 
made between intake and disease. Furthermore, the complexity of the human diet makes 
it difficult to isolate the health effect of individual dietary phenols (Hollman et al. 2001) 
or their biologicaly relevant metabolites. Differences in agricultural practices, season, 
processing, portion of food used, or amount of food or food component used all serve to 
alter flavan-3-ol exposure and perhaps outcomes observed in epidemiological and 
experimental settings (Clifford et al. 2004).  
 
1.4.5 Protective Mechanisms Associated with Flavan-3-ols 
Reactive oxygen, nitrogen, and halide species in amounts that overwhelm 
antioxidant defense systems result in oxidative stress that lead to damage to cells and 
change cell signaling pathways, initializing ageing and disease processes (Kontic-Vucinic 
et al. 2008; Wang et al. 2006a; Pong 2003). The health-promoting activity most 
commonly associated with flavan-3-ols has been their antioxidant activity (Halliwell et al. 
2005) derived from the multi-phenolic structure that allows polyphenols to reduce 
reactive oxygen species by donating an electron transforming into an aryloxyl radical 
with an unpaired electron stabilized over its aromatic rings (Dangles et al 2012). These 





propagation route by reacting with other free radicals (Shahidi et al 1992). Polyphenols 
can also indirectly act as antioxidants by chelation of divalent metal ions involved in pro-
oxidative reactions including Fenton and Haber-Weiss reactions (Duthie et al 2000) or by 
stimulating the body’s endogenous antioxidant systems (Li et al. 2006; Chandronitha et al. 
2010; Yuan et al. 2007).   
Flavan-3-ols have demonstrated the ability to regenerate endogenous antioxidants 
and stimulate defense mechanisms of cells by up-regulating expression of antioxidant 
enzymes (Dangles et al. 2012). As little as 0.05 μM of procyanidins from grape seed 
extract enhanced endothelial NO-synthase-mediated relaxation in internal mammary 
aortic rings, indicative of cardioprotective effects (Aldiniet al. 2003).  In addition, a 
cocao extract inhibited CYP1A activity reducing the mutagenicity of benzo[a]pyrene by 
limiting its biotransformation to the ultimate carcinogenic form (Ohno et al. 2009). Apple 
polyphenols including C and EC induced glutathione S-transferase, a phase II gene 
involved in xenobiotic detoxification, in colon epithelial cells (Petermann et al. 2009). In 
a study by Manna et al. 2009, tea polyphenols restricted benzo[a]pyrene-induced lung 
carcinogenesis in mice indicated by altered expression of p53-associated genes. 
Furthermore, EGCG increased protein levels of Nrf2 and mRNA levels of UGTs in nude 
mice, suggesting EGCG activates the Nrf2-UGT1A pathway (Yuan et al. 2007). 
Flavan-3-ols have also demonstrated the ability to modulate cell-to-cell 
communication by upregulating intracellular gap junction communication. For example, 
cocoa flavan-3-ols including EC and C have been shown to attenuate hydrogen peroxide-





epithelial cells through antioxidant activity and direct inhibition of mitogen-activated 
protein kinase (MEK) 1 activity (Lee et al. 2008).   
  
1.5 Overview of Bioaccessibility and Bioavailability of Flavan-3-ols 
While many biological activities have been proposed and explored for flavan-3-
ols, it is important to consider the ability of these individual species to cross the intestinal 
barrier and be made availabile for tissue uptake and utilization.  Therefore bioavailability 
of flavan-3-ols has been increasingly a topic of focused research and subject of many 
comprehensive reviews. The term bioaccessibility is used to refer to the pre-
absorptive/digestive release and solubilization of compounds from food matrices by 
digestive enzymes or bacterial microflora present in the gut. Compounds that are stable to 
gut luminal condition (e.g. enzymes, pH and oxidative environment) during digestion 
(digestive stability) are described as available for subsequent absorption in the intestine 
(bioaccessible) (Saura-Calixto et al. 2007) (Figure 4). The stability of flavan-3-ols during 
digestion as well as their metabolism by mammalian phase I and phase II systems and 
transformation by microbiota are subject of extensive reviews (Spencer et al. 2003; 
Ferruzzi et al. 2012; Monagas et al. 2010).  This review will primarily highlight key 
aspects of oral, gastric and intestinal processing as it related to flavan-3-ol 








Figure 4: A schematic outlining the concept of bioaccessibility and bioavailability of 
bioactive components after consumption. 
 
1.5.1 Oral Phase 
Mechanical break-down of the food matrix and enzymatic degradation of 
carbohydrates by salivary α-amylase at near neutral pH occurs during the oral phase of 
digestion. Flavan-3-ol-protein interactions have been well described in this phase of 
digestion. Proline-rich salivary proteins have demonstrated the ability to interact with 
flavan-3-ol monomers and polymers resulting in an “astringent” response (Bajec et al. 
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ability of these interactions to stabilize flavan-3-ols (Tsuchiya 1997) and prevent 
association of flavan-3-ols with digestive enzymes, mitigating the potential antinutritive 
effect associated with complex polyphenol polymers (tannins) (Lu et al. 1998; Prinz et al. 
2000) further down the GI tract. Additional modifications to flavan-3-ols during the oral 
phase may include potential for degalloylation of EGCG to EGC by esterase activity in 
human saliva (Yang et al. 1999).  However, this notion remains controversial as the 
presence of esterases in saliva remains a topic of intense debate. In general, oral 
processing is not believed to induce significant changes to flavan-3-ol structure or 
availability other than through interaction of free flavan-3-ols with salivary proteins. 
 
1.5.2 Gastric Phase 
Orally processed food or beverages containing flavan-3-ols is passed from the 
oral cavity into the stomach where digestion of the food matrix continues in the gastric 
environment. Mechanical break-down by mixing as well as initial digestion of the food 
matrix by pepsin occurs at low pH during this phase. Monomeric flavan-3-ols are 
generally water soluble and stable to low pH (2-4) (Spencer et al. 2000; Uzunović & 
Vranić 2008), and thus begin to be extracted from the partially digested food matrix and 
solubilized in the stomach during chyme formation. In vitro studies suggest that after 
solubilization, flavan-3-ol polymer proanthocyanidins (PACs) may be hydrolyzed to 
smaller units or monomers (Spencer et al; 2000, Kahle et al. 2011; Rios et al. 2002). 
However, as with esterase activity, evidence of depolymerization of PACs in the stomach 
remains limited and it is generally believed that flavan-3-ols in all forms remain generally 





2007).  While certain phenolics/polyphenols, such as anthocyanin, quercetin, chlorogenic 
acid and phenolic acids, may be absorbed in the gastric environment (Passamonti et al. 
2005; Konishi et al. 2006; Lafay et al. 2006; Crespy et al. 2002; Vanzo et al. 2007), most 
flavonoids, including flavan-3-ols, are not absorbed in this portion of the GI tract to any 
significant extent.  However, proposed mechanisms for absorption of polyphenols in the 
stomach include passive trans-epithelial diffusion (Tsuji et al. 1996) and carrier-mediated 
trans-epithelial diffusion (Vanzo et al. 2007) as well active transport by billitranslocase 
(Passamonti et al. 2002) 
 
1.5.3 Small Intestine 
Gastric chyme containing partially digested food and partially bioaccessible 
flavan-3-ols is released from the stomach into the upper small intestine (duodenum) for 
further digestion. Bile salts, pancreatic enzymes including lipase, trypsin, α-amylase, and 
elevated pH (pH 6-7.5) (Fallingborg 1999) are characteristic of small intestinal conditions. 
Flavan-3-ols appear to be susceptible to oxidative degradation at this stage of digestion, 
possibly due to oxidative processes occurring in the presence of both reactive oxygen 
species and elevated pH conditions (>5.5) (Yoshino et al. 1999; Zhu et al. 2002a; Green 
et al. 2007; Neilson et al. 2007; Ferruzzi et al. 2010). Additionally, flavan-3-ols may 
epimerize during the duodenal phase (Kahle et al. 2011) generating higher proportions of 
C, GC and GCG forms from predominant epi forms in food and beverages. 
Intestinal absorption of polyphenols and flavan-3-ols has been subject of 
extensive reviews (Scalbert et al. 2000; Manach et al. 2004; Monagas et al. 2010). Extent 





(Baba et al. 2000) and galloylation (Auger et al. 2008; Stalmach et al. 2009; Stalmach et 
al. 2010; Lee et al. 2002). Absorption from the small intestine is limited to flavonoid 
aglycones such as flavan-3-ols and select O-β-D-glucosides (Dangles et al. 2012). O-β-D-
glucosides can be hydrolyzed by lactase phlorizin hydrolase to its aglycone form and 
absorbed via passive diffusion as a result of its increased lipophilicity and its proximity to 
the cellular membrane (Day et al. 2000). Absorption directly through a sodium-dependent 
glucose transporter (SGLT1) intact (Walgren et al. 2000; Wolffram et al. 2002) as well as 
intracellular hydrolysis by cytosolic β-glucosidase have been demonstrated (Day et al. 
2003). Flavan-3-ols are the flavonoids that are most commonly present as aglycosides in 
the diet, therefore their monomers may be absorbed directly in the small intestine for 
further metabolism by passive or carrier-mediated diffusion (Henning et al. 2008). 
Enzymes active in transport of flavan-3-ols include monocarboxylate transporter (MCT) 
and organic anion transport protein B (OATP-B).  OATP-B is a pH dependent transporter 
that aided in passive absorption of quercetin into small intestine epithelial cells in vitro 
(Chabane et al. 2009). MCT1 catalyzes proton-coupled transport of flavonoids. ECG was 
transported in vitro, and multiple flavonoid agylcones were transported both in vitro and 
in vivo by MCT1 (Vaidyanathan & Walle 2003; Wang 2007). Generally, monomeric 
flavan-3-ols reach Tmax in plasma at 1.5 hours after ingestion (Manach et al. 2005). 
However flavan-3-ol oligomers and polymers with degree of polymerization over three 
are not believed to be absorbed effectively and are passed to the colon where further 
metabolism by colonic microbiota is possible (Manach et al. 2004; Donovan et al. 2006).   
Once present in the enterocyte, various xenobiotic “Phase II” metabolizing 





intestine, and sulfotransferases (SULT) and catechol-O-methyltransferases (COMT), also 
present in the liver, begin to biotransform flavan-3-ol aglycones to sulfate, glucuronide, 
and/or methylated metabolites. These conjugated metabolites are further distributed in 
circulation and can also be effluxed back into the lumen of the small intestine. UGT1 is 
the enzyme considered responsible for flavonoid glucuronidation (Cheng et al. 1999). 
Conjugation of EC occurs at C-3’ and C-4’ (B ring) and C-5 and C-7 (A ring) hydroxyl 
groups, resulting in monoglucuronide, sulfate, methyl ester, or combined derivative forms 
(Baba et al. 2000; Natsume et al. 2003; Schroeter et al. 2006). The main glucuronide 
derivative of both EC and EGC is 3’-O glucuronide (Natsume et al. 2003; Li et al. 2001; 
Lu et al. 2003; Urpi-Sarda et al. 2009). However, after consumption of cocoa, O-sulfated 
metabolites of EC have been reported as predominant urinary metabolites (Roura et al. 
2008) and following consumption of tea, EGC metabolites identified include 3’- and 7-O 
glucuronides and 4’-O methyl and its derivatives (Sang et al. 2008a; Sang et al. 2008b; Li 
et al 2001; Meng et al. 2002; Lu et al. 2003). EGCG metabolites were primarily 
methylated on B and D rings in cytosol samples from CF-1 mice, Sprague-Dawley rat, 
and human liver and in biliary fluids of Wistar rats (Lu et al. 2003; Kida et al. 2000). 
Prominent EGCG metabolites found in human and rat sera include 4’,4”-di-O-
methylEGCG, and 4”-O-methylEGCG (Meng et al. 2002). Interestingly, EGCG may also 
reach plasma unmetabolized: it was reported as the only unmetabolized flavan-3-ol from 
ready-to-drink green tea recovered in human plasma, and was present at higher 
concentrations than EGC and EC metabolites (Del Rio et al. 2010). 
With regards to procyanidins, dimeric procyanidins have been detected at very 





seeds (Holt et al. 2002; Sano et al. 2003). Both procyanidin dimers and trimers have also 
been detected in Sprague-Dawley and Wistar rat plasma after ingestion of cocoa extracts 
(Baba et al. 2002; Zhu et al. 2002b) and cocoa cream and hazelnut skin extracts (Serra et 
al. 2013). Also, only native and methylated procyanidin dimer metabolites were found in 
Wistar rat plasma (Shoji et al. 2006).  However, in general, bioavailability of dimeric 
forms was reported to be significantly lower than monomeric flavan-3-ol forms.   
The adenosine triphosphate (ATP)-binding cassette (ABC) family of transporters 
including multidrug resistance protein (MRP) and P-glycoprotein (P-gp) are responsible 
for efflux of polyphenolic metabolites from intestinal enterocytes back to the gut lumen 
thereby limiting overall trans-cellular transport and oral bioavailability of flavan-3-ols. 
Metabolites that are passed to the bloodstream may undergo further metabolism in the 
liver and kidney. Additionally, absorbed or hepatic metabolites may be subsequently 
recycled to the small intestine via enterohepatic transport in bile (Crozier et al. 2009; 
Prasain et al. 2007; Clifford et al. 2004).  Overall, flavan-3-ols and their conjugated 
metabolites are generally poorly absorbed in the small intestine, and as a consequence, 
their concentrations in plasma rarely exceed 1 μM (Manach et al. 2005). However, 
intestinal tissues do appear to be a main site for their accumulation as indicated by animal 
studies (Suganuma et al. 1998; Janle et al. 2010; Swezey et al. 2003).  
 
1.5.4 Colon 
About 90-95% of ingested polyphenols reach the colon after consumption 
(Clifford et al. 2004) where they are extensively metabolized by colonic microbiota 





cleaveconjugated moieties to aglycones, which are then subjected to subsequent ring 
fission and other metabolic conversion. In general these processes lead to production of 
smaller molecular weight benzoic acid, hydroxycinnamate and other phenolic acid 
derivatives (Crozier et al. 2009). Millimolar concentrations of benzoic acid, phenylacetic 
acid, and phenylpropionic acid derivatives can result from this catabolism (Williamson & 
Clifford, 2010) and have been subsequently detected in urine of animals treated with 
polyphenols (Sang et al. 2008; Crozier et al. 2009).  
Galloylated flavan-3-ols are catabolized first via cleavage of gallic aid, followed 
by decarboxylation of gallic acid to pyrogallol (Meselhy et al. 1997; Kohri et al. 2003; 
Roowi et al. 2010) and opening of the C-ring. Subsequently, conversions to γ-
valerolactone (Meselhy et al. 1997; Roowi et al. 2010, Groenewoud & Hundt 1984) and 
valeric acid (Kohri et al. 2003) followed by transformation of valeric acid to 
hydroxyphenylpropionic and hydroxybenzoic acid via β-oxidation may occur. 
Catabolized flavan-3-ols are then metabolized in the liver by phase II enzymes and 
subsequently eliminated in urine or feces. Interestingly, a recent study showed that after 
green tea consumption, polyhydroxyphenyl-γ-valerolactones were present at 10x the 
concentration in urine than any other metabolites (Sang et al. 2008).  
These microbial metabolites may also be absorbed, distributed through the body 
and ultimately excreted in urine at much higher quantities than the parent flavan-3-ol and 
primary phase II metabolites absorbed in the small intestine (Crozier et al. 2009). 
Evidence shows benzoic, salicylic, p-coumaric, and ferulic acids may be transported 
actively by monocarboxylate transporter MCT1 (Tsuji et al. 1994; Takanaga et al 1994; 





Phase II enzymes in the gut and liver (Clifford et al. 2004). In addition, carrier-mediated 
transport was involved in absorption of ferulic acid in an in vitro model for colonic 
epithelium (Poquet et al. 2008).   
 
1.6 Food Matrix Interactions 
While bioavailability of polyphenols is reported to be poor, the notion that this 
limited absorption can be modulated by specific food matrix interactions has been subject 
of several lines of investigation. Specifically, factors that alter stability in foods and 
beverages, their digestive release and stability in the gut (bioaccessibility) or their 
transport/metabolism by the gastrointestinal epithelium may all provide avenues to 
positively affect flavan-3-ol bioavailability (Parada & Aguilera 2007; Neilson & Ferruzzi, 
2011).  While polyphenol-micronutrient and polyphenol-polyphenol interactions have 
been subject of several investigations, polyphenol-polysaccharide and polyphenol-protein 
interactions have also demonstrated several specific effects on polyphenol bioavailability.  
Considering the focus of this thesis on flavan-3-ol-protein interactions, the influence of 
these macronutrients is therefore the focus of this section. 
 
1.6.1 Polysaccharide-Polyphenol Interactions 
Phenolic and polyphenolic compounds in plants can be defined as extractable 
(EPP), or non-extractable (NEPP) (Chandrasekara & Shahidi, 2011). NEPP’s mainly 
form complexes with polysaccharides associated with the cell wall (Ferguson et al. 2001) 
and are not directly bioavailable in the small intestine (Manach et al. 2005), but can be 





absorbable metabolites. These metabolites are typically phenolic acids, such as 
hydroxyphenylacetic, phenylpropionic, and phenylbutryric acids (Saura-Calixto et al. 
2010a; Saura-Calixto et al. 2010; Selma et al. 2009).   
While these direct, covalent interactions are well known to limit availability of 
phenolics, other associations with plant cell walls and polysaccharides may serve to limit 
bioaccessibility of polyphenols in the gut lumen.  For example, flavan-3-ols with a 
galloyl group (such as EGC and EGCG and ECG) are more able to interact non-
covalently with β-glucan fibers than those without (Gao et al. 2012). Additionally, 
anthocyanins, which are charged species, have been reported to interact with plant cell 
wall polysaccharides including pectin and lignins after ingestion, likely facilitating their 
transport to the colon and limiting their absorption in the stomach and small intestine 
(Padayachee et al. 2012). As such, the majority of anthocyanins only become 
bioavailable following colonic digestion which includes microbial fermentation of plant 
polysaccharides and metabolism of flavonoid backbones (Williamson & Clifford, 2010).  
In addition to effects of polyphenols in complexation with cell wall material on 
polyphenol bioavailability, effects related to polyphenol bioactivity have been shown. In 
a study by Jacob et al. 2008, twenty-five percent of polyphenols from a grape juice 
concentrate were nondialyzable. These complexes had different anthocyanin conjugates 
and exhibited reduced radical scavenging activity compared to dialyzate, possibly due to 
differences in anthocyanin composition and to complex formation. However, non-
extractable procyanidins in fruit showed positive correlations with bile acid binding, 
which has been implicated in lowering cholesterol (Rideout et al. 2008), and radical 





interactions may also compete with and thus inhibit interactions between polyphenols and 
digestive enzymes in the gut lumen. For example, polysaccharides (arabic gum, β-
cyclodextrin, and pectins) reduced polyphenol interactions with α-amylase (Soares et al. 
2009), an interaction associated with harmful effects such as decrease in body weight 
gain (Griffiths et al. 1986). 
Finally, presence of digestible carbohydrate (starch or sugars) appears to 
positively influence intestinal uptake and transport of select polyphenols.  Uptake of 
monomeric procyanidins from grape seed procyanidin extracts (300 mg) was enhanced 
by co-ingestion of a carbohydrate-rich food (600 mg; containing hydrolyzed wheat, 
wheat, barley, maize, and oats) (Serra et al. 2010). A similar positive effect of 
carbohydrate on flavan-3-ol absorption was noted in both animal and human clinical 
studies on tea (Peters et al. 2010) and cocoa (Schramm et al. 2003; Nielson et al. 2009; 
2010). However, Maillard reaction products slightly reduced chlorogenic acid absorption 
(Dupas et al. 2006a). The ability of non-digestible carbohydrates to both associate and 
limit bioaccessibility of and digestible carbohydrate to potentiate absorption of flavan-3-
ols further complicates the design and interpretation of many bioavailability studies.  This 
may be due in part, to direct effects to GI motility, or by association with carbohydrate-
flavan-3-ol transporters including SGLUT1, GLUT2 and MCT.  However, the extent to 







1.6.2 Protein-Polyphenol Interactions 
1.6.2.1 Mechanisms and Factors Affecting Interactions 
Polyphenols have been reported to bind to several biologically relevant proteins 
including common food proteins (milk, soy and cereal), proline rich salivary proteins, 
digestive enzymes, and plasma proteins. These interactions are believed to potentially 
influence biological activities and bioavailability of polyphenols. As such, it is not 
surprising that the mechanims of these interactions have been subject of several studies. 
Examples of types and strengths of specific interactions between select proteins and 
polyphenols are summarized in Table 2.  Central to these interactions is hydrophobic 
stacking of aromatic amino acid side chains within protein to those of dipoles within 
polyphenols generated by London forces (Yuksel et al. 2010).  Combined with hydrogen 
bonding interaction of hydroxyl groups of polyphenols with protein chains these forces 
have been reported to be major driver of such interactions.  Both of these interactions 
may induce changes in protein structure, depending on the protein involved (Hagerman et 






Table 2: Binding kinetics and mechanisms of protein-(poly)phenol interactions. 
Protein Polyphenol pH Binding Affinity (K) Binding Mechanism Reference 
α-casein 





Hasni et al.  
2011  
(-)-EC 7.4 1.8x103M-1 
(-)-EGC 7.4 2.4x103M-1 
(-)-EGCG 7.4 7.4x103M-1 
β-casein 





Hasni et al.  
2011  
(-)-EC 7.4 2.5x103M-1 
(-)-EGC 7.4 3.5x103M-1 
(-)-EGCG 7.4 1.59x104M-1 
β-lactoglobulin 




Kanakis et al.  
2011  
(-)-EC 7.4 3.2x103M-1 
(-)-EGC 7.4 1.1x104M-1 
(-)-EGCG 7.4 1.3x104M-1 
α-amylase 




Soares et al.  
2007  




procyanidin B4 5 1.4x104M-1 
BSA 





surface of protein 





chlorogenic acid 7 4.5x103M-1 
Hydrogen-bonding Sastry & Rao  1990  chlorogenic acid 5.5 3.8x103M-1 
 
Interactions involved in protein-polyphenol interactions include hydrophobic 
interactions (specifically London forces), hydrogen binding, and electrostatic interactions. 





interactions, while hydrogen bonds tend to stabilize interactions (Murray et al. 1994; 
Papadopoulou et al. 2005; Xu and Chen 2011; Prigent et al. 2003; Jöbstl et al. 2006). For 
those polyphenols that are elongated and less hydrophobic, hydrogen bonding forces are 
more important than hydrophobic interactions, while compact hydrophobic polyphenols 
primarily interact with proteins through hydrophobic interactions (Hagerman et al. 1998). 
There have been less reports of involvement of electrostatic interactions in formation of 
protein-polyphenol complexes, however evidence exists that showssuch interactions may 
play a key role (Xu & Chen 2011).  
Structural characteristics of polyphenols impact their affinity to bind protein. 
Binding appears to increase with polyphenol molecular weight, due to presence of 
aromatic rings that increase hydrophobicity and binding (Soares et al. 2007; Baxter et al. 
1997; de Freitas et al. 2001). Large polyphenols may interact with proteins through 
multidentate association (Baxter et al. 1997; Charlton et al. 2002; de Freitas et al. 2001; 
Jöbstl et al. 2006). Alternatively, they may have low conformational mobility and thus 
low binding affinity for proteins (Soares et al. 2007; de Freitas et al. 2001; Baxter et al. 
1997).  
Substitution pattern on the polyphenol structure may also impact affinity for 
protein. For example, polyphenol galloylation increases binding interactions by initiating 
binding to either several sites on the same protein or in different protein molecules 
through hydrophobic effects and hydrogen binding (de Freitas et al. 2001; Baxter et al. 
1997; Xiao et al. 2011; Xu & Chen 2011; Soares et al. 2007). Binding is also improved 
with increased hydroxylation. Specifically, hydroxyl groups on A and B rings of flavones 





significantly improved interactions (Xiao et al. 2011; Xu & Chen 2011), and presence of 
ortho phenolic hydroxyl groups appeared to increase interactions (de Freitas et al. 2001). 
Studies have also shown that structural characteristics of polyphenols that tend to 
decrease their affinity to protein include methylation, methoxylation, glycosylation, and 
hydrogenation of C2=C3 double bond (Xiao et al. 2011; Xu & Chen 2011; Papadopoulou 
et al. 2005). 
Protein structure also influences formation of protein-polyphenol interactions. 
Studies show that proline residues on proteins are important for polyphenol binding, and 
proline residues followed by prolines are geometrically preferred polyphenol binding 
sites. Phenylalanine is another important amino acid that promotes interactions, although 
it is usually buried due to its hydrophobic nature. Histadine has been shown to be both 
important and unimportant in protein-polyphenol interactions (Yan et al. 1995; Naurato et 
al. 1999; Charlton et al 2002). Finally, arginine does not independently interact with 
polyphenols, however it appears to be associated with strengthening interactions (Baxter 
et al. 1997; Charlton et al. 2002; Soares et al. 2007). 
As discussed, flavonoid interactions are typically within hydrophobic pockets and 
to hydrophobic residues of proteins (Papadopoulou et al. 2005; Soares et al. 2007). The 
size of the protein’s hydrophobic cavity may thus dictate types of polyphenols the protein 
can interact with (Soares et al. 2007). Extent of protein secondary structure may therefore 
also dictate protein binding potential and potential sites. For example, globular proteins 
generally lack proline on their surface, whereas randomly coiled proteins have an 






Stacking interactions between aromatic functions are also frequently involved in 
protein-polyphenol interactions (Baxter et al. 1997; Murray et al. 1994). The mechanism 
for binding between EGCG and proline-rich proteins has been investigated. The major 
conformation between proline-rich proteins and EGCG is the A ring over Pro5, D ring 
over Pro4, and B ring close to Arg (Charlton et al. 2002). Furthermore, changes in protein 
secondary structure due to protein-polyphenol interaction have been observed (Kanakis et 
al. 2011; Hasni et al. 2011). 
Polyphenol-protein interactions are also dependent on several factors including 
polyphenol/protein ratio (Pascal et al. 2007), pH, temperature, and ionic strength in the 
context of solutions (Wang et al. 2010; von Staszewski et al. 2011, 2011b). Increasing 
both solution temperature and ionic strength promoted hydrophobic interactions between 
polyphenol and protein (Wang et al. 2010). Increasing ionic strength increased protein-
polyphenol interactions by increasing electrostatic repulsions between protein/peptides, 
decreasing protein-protein interactions that occur at the protein’s isoelectric point (pI). 
 
1.6.2.1.1 Mechanisms and Factors Affecting Flavan-3-ol Protein Interactions 
With specific regards to flavan-3-ols, interactions depend on structure of both 
flavan-3-ol and protein. For example, proteins with higher proline content favor 
polyphenol binding, and gallation of flavan-3-ols (EGC, EGCG, ECG, CG, GCG, GC) 
increases affinity of the compound to protein (Poncet-Legrand et al. 2007). Furthermore, 
size of the protein’s hydrophobic cavity affects its interactions with flavan-3-ols: bovine 





gallated flavan-3-ols, whereas human salivary α-amylase has a multi-domain structure 
with small cavities optimal for binding small phenolics/polyphenols, such as gallic acid 
(Soares et al 2007).  
Considering the common addition of milk to tea, it is no surprise that the 
interaction between tea flavan-3-ols and milk proteins has been explored. The primary 
interactions involved in complexation of flavan-3-ols and proteins were reported to be 
hydrophobic associations between flavan-3-ol rings and hydrophobic pockets of α- and 
β- casein and β-lactoglobulin. Hydrogen bonding interactions are believed to be involved 
in stabilization of these complexes. Binding of flavan-3-ols to caseins and β-lactoglobulin 
occurred primarily on the surface and within hydrophobic pockets of the protein, 
respectively. Increased polyphenol concentration decreased casein secondary structure 
leading to protein unfolding, but altered β-lactoglobulin secondary structure leading to 
stabilizion of protein structure under experimental conditions (Hasni et al. 2011; Kanakis 
et al. 2011). 
 
1.6.2.2 Impact of Polyphenol-Protein Interactions on Food Quality 
Effect of protein interactions with flavan-3-ols in complex foods has been a topic 
of several studies due, in part, to potential for the interactions to alter protein physical 
stability, product quality and also flavan-3-ol stability/activity. This has been most 
important with regards to beverage quality with specific respect to haze in juice, wine, 
and beer. Haze active proteins from cereals and fruit juices are active over a wide 





by virtue of their proline content (Asano et al. 1982). Simple phenols and polyphenol 
monomers generally are not associated with haze (Asano et al. 1984). However larger 
flavan-3-ol dimers and polymers have haze activity that increases with polymerization 
(Mulkay & Jerumanis, 1983). Most haze is accentuated at lower temperatures that favor 
formation of hydrophobic and specific electrostatic interactions. These interactions are 
reversible and visually apparent haze can be reduced or eliminated when the beverage is 
warmed (Asano et al. 1982). Haze may also be prevented by prohibiting presence of 
oxygen from the system (Wall et al. 1996) and decreasing oxidation and polymerization 
of polyphenols. It may be reduced by adsorption of haze active proteins and polyphenols 
(Siebert and Lynn 1997a,b,c; 1998) and by utilization of enzymatic hydrolysis of haze 
active protein (de Clerck et al. 1969). 
Impacts of polyphenol interactions with dairy protein on beverage nutrition and 
quality attributes have increasingly been studied due to common formulation of tea and 
cocoa with milk (Table 3).  Potential for both interaction and oxidative processes in these 
systems creates a beverage matrix that does not favor delivery of flavan-3-ols.  For 
example, addition of as little as 5% milk to tea was reported to decrease antioxidant 
activity of flavan-3-ol rich tea solutions as measured using both azinobis (3-
ethylbenzothiazoline-6-sulfonate) diammonium salt (ABTS+) and voltammetry assays. 
This may have been due, in part, to binding and eventual precipitation of protein-
polyphenol complexes thereby decreasing the amount of polyphenols available to react 
with oxidants in solution. A pronounced effect was observed in English breakfast tea 
models compared to Darjeeling and green teas, possibly due to presence of condensed 





larger extent than flavan-3-ol monomers (Dubeau et al. 2010). The extent to which this 
effect was due to binding or a combination of binding and oxidative damage to 
polyphenols at elevated pH is not known.  Conversely, the same study reported that tea 
antioxidant activity was increased in a lipid emulsion system, conceivably due to a 
synergistic effect between milk and tea polyphenols resulting from either facilitated 
deprotonation of polyphenols or creation of a physical protective barrier to lipid micelles.  
 
Table 3: Impact of milk addition on antioxidant capacity of phenolic and polyphenolic 
rich beverages. 
Beverage Main phenolic class Antioxidant Capacity Reference 
Coffee Flavan-3-ols, Phenolic acids Decreased; No effect Niseteo; Dupas et al. 2006b 
Tea Flavan-3-ols Decreased Dubeau et al. 2010 
Cocoa Flavan-3-ols, Phenolic acids Decreased Belscak et al. 2009 
Black tea Monomeric and Polymeric 
Flavan-3-ols 
Increased Sharma et al. 2008 
 
 
A study by Sharma et al. 2008 also produced results that initially appear 
conflicting. Formulation of milk (40%) to black tea decreased total free polyphenols and 
radical scavenging capacity measured using the 1,1-diphenyl-3-picrylhydrazyl (DDPH) 
model. This effect was presumably due to non-covalent interactions between polyphenol 
and protein. However, addition of milk, sugar, and their combination increased 
antioxidant activity in a β-carotene-linoleic acid model system. Antioxidant activity may 
have been more prevalent in the linoleic acid system compared to the DDPH model 





peroxidation, but have low reactivity with the nitrogen radical in the DDPH model 
(Huang et al. 2005). These confounding effects make it difficult to fully interpret impact 
of flavan-3-ol-protein interactions. 
Apparent masking of flavan-3-ol antioxidant capacity by milk proteins depends 
on structure of both protein and flavan-3-ols and follows typical binding parameters 
previously described. For example, Arts et al. 2002 concluded that a C3 gallate group 
increases extent of interaction between flavonoids and milk protein, while a 5’OH group 
decreases interaction.  They also showed that proteins high in proline are likely to interact 
with hydroxyl groups of flavonoids. For example, the greatest antioxidant masking of 
EGCG (bearing a gallate group at the 3 position on C ring) and gallic acid occurred in 
combination with β-casein (a protein high in proline). In a similar study, precipitation of 
polyphenols by whey proteins from whey protein concentrate increased with green tea 
gallic acid equivalents, and antimicrobial activity decreased with protein concentration 
(von Staszewski et al. 2011b). This presumably indicates a decreased availability of 
bioactive flavan-3-ols for reactivity.  
Additionally, salt concentration may have an impact on protein-polyphenol 
interactions. Whey protein concentrates with higher salt concentration (indicated by ash 
content) bound less effectively compared to those with lower salt concentration due to a 
‘screening’ effect (von Staszewski et al. 2011b). Divalent cations including iron, copper, 
calcium, and magnesium may interact with electron dense phenolic rings of flavan-3-ols 
rendering them unavailable for participation in flavan-3-ol-protein interactions. Many 
studies have also demonstrated interactions between catechols and flavonoids with 





2009). Suggested mechanisms include chelation of salts by either two hydroxyl groups 
within catechols or by formation of salt bridges between multiple catechols (Yamada et al. 
2007). These interactions have several effects on flavonoid stability and chromophore 
(Vitali et al. 2008; Al-Numair 2009; Mori et al. 2006; Lee et al. 2005) suggesting they 
may also modulate the ability of individual flavonoids to interact with proteins. 
 
1.6.2.3 Impact of Polyphenol-Protein Interactions of on Polyphenol Bioavailability 
Digestion and absorption of polyphenols have been previously discussed. 
Potential impact and interaction sites between protein and polyphenol are further outlined 
in Figure 5. It is clear that co-consumed proteins and polyphenols may interact 
throughout the digestive process. In fact potential impact of polyphenol-protein 
interactions on bioaccessibility and bioavailability of flavan-3-ols has been previously 
studied both in vivo and in vitro.  Similar to effects on antioxidant activity and product 






Figure 5: A schematic outlining bioavailability and bioaccessibility of proteins and 
polyphenols. Interactions between polyphenols and proteins/peptides may occur during 






Table 4: Impact of milk addition on in vivo bioavailability of polyphenols from foods and 
beverages in humans. 






Bioavailability Boiled Reference 
Black tea Total flavan-3-ol 196-203mg 2.3g 
Yes; plasma AUC 
decreased from 1.14 to 
0.95μmol/l over 3 
hours 
Yes Reddy et al. 2005 
Green tea, black 
tea Total flavan-3-ol 




3.3g No affect on plasma AUC over 8 hours No 
van het Hof  et 
al. 1998 




~20mg flavonol  in 
both types tea 3.9g 
No affect on plasma 
AUC over 2 hours Yes 
Hollman et al. 
2001 
Black tea Total flavan-3-ol 395umol flavan-3-ol 3.3g 
No affect on plasma 
concentration (μmol) 
over 3 hours 
Yes Kyle et al. 2007 
Cocoa 
(beverage) C, (-) EC 
2.0 - 2.7g 
polyphenol 2.45g 
No affect on plasma 
concentration (μmol/l) 
over 6 hours 
No Keogh et al. 2007 
Cocoa 
(beverage) EC-glucuronide 64mg polyphenols 8.1g 
No affect on plasma 
concentration (nmol/l) 
in after 2 hours 
No Roura et al. 2007 
Cocoa 
(beverage) (-)EC, flavan-3-ol 
1.5mg/kg body 
weight 
 (about 100mg) 
260mg/kg 
 (17.4g) 
No affect on plasma 
Cmax or AUC over 8 
hours 
No Schramm et al. 2003 
Cocoa (solid) (-)EC Not specified 6.5g 
Yes; decreased plasma 
AUC by 46% over 4 
hours when cocoa 
consumed with milk, 
and 69% when solid 
cocoa contained milk 
No Serafini et al. 2003 
Cocoa (solid) (-)EC 36mg 8.1g 
No affect on Cmax or 
Tmax over 6 hours by 
addition of milk 
protein  to solid cocoa 
formulation 
No Neilson et al. 2009 
Blueberry fruit Caffeic acid,  ferulic acid 250mg polyphenol 6.5g 
Yes; plasma AUC 
decreased by 49.7 and 
19.8%, respectively, 
over 5 hours by 
consumption of 
blueberry with milk 
No Serafini et al. 2009 
 
 
Several human studies have directly investigated the impact of milk on absorption 
of flavan-3-ols from tea (Table 4). Plasma flavan-3-ol concentration was higher in human 





However, in contrast, bioavailability of flavan-3-ols from both green tea (van het Hof et 
al. 1998) and black tea (van het Hof et al. 1998; Kyle et al. 2007) were not affected by 
formulation with milk (17 and 25%) in healthy human subjects. Similarly, impact of 
green tea temperature on flavan-3-ol bioaccessibility from tea beverages formulated with 
and without milk was investigated with conflicting results (Table 5). Boiling green tea 
beverages enhanced in vitro bioaccessibility, and addition of milk to heated beverages 
decreased digestive recovery of flavan-3-ols to a greater extent compared to matching 
solutions at ambient temperature (Xie et al. 2012).  This result may suggest increased 
protein-polyphenol interactions at elevated temperature. This effect may be due to 
increased exposure of surface hydrophobic residues on protein due to its denaturation, 
increasing its ability to interact with polyphenols through London forces. However, no 
apparent temperature-related trend for protein-polyphenol interactions is obvious when 
comparing across tea consumption and bioaccessbility studies (Tables 4 and 5).  
 
Table 5: Impact of milk addition on in vitro bioaccessibility of polyphenols from foods 
and beverages. 






Bioaccessibility Boiled Reference 
Green tea  
extract 
EGC, EC, EGCG, 
GCG, ECG 75 mg/mL 10 or 25% v/v Yes Yes, No Xie et al. 2012 
Green tea EGC, EC, EGCG, ECG 60mg/mL 10, 20, 50% v/v Yes Yes Green et al. 2007 
Black tea Total flavan-3-ols 1.8 mol/L 5.6-40% No Yes 
van der Burg-








Similarly to studies with tea, bioavailability of flavan-3-ols from cocoa has also 
been studied with mixed findings (Table 4). Formulation of cocoa beverages with milk 
had no effect on plasma concentration of C, (-)-EC, and EC-glucuronide compared to 
controls (Keogh et al. 2007; Schramm et al. 2003; Roura et al. 2007). Conversely, in vivo 
bioavailability of (-)-EC from solid cocoa decreased to a significant extent in a study by 
Serafini et al. 2003, and modestly in another study (Neilson et al. 2009). Discrepancy in 
results between beverages and confections suggest that the physical state of the food 
matrix may impact protein-polyphenol binding during digestion, possibly due to affects 
on gastrointestinal motility and/or rate of flavan-3-ol solubilization in the gut (Neilson et 
al. 2009). 
Interestingly, similar decreases in bioavailability have been observed in other 
foods/beverage phenolics (Table 4).  Consumption of blueberries with milk resulted in a 
decrease in plasma concentrations of caffeic and ferulic acid in vivo (Serafini et al. 2009).  
While milk addition to coffee did not impact bioavailability of chlorogenic acid, addition 
of nondairy creamer slowed absorption (delay in Tmax) of chlorogenic acid in humans 
(Reneuf et al. 2010).  These data suggest that milk protein interactions with phenolics 
may have diverse impact on bioavailability measures. 
 
1.6.2.4 Impact of Polyphenol-Protein Interactions on Biological Activities in vivo 
Beyond absorption, ability of flavan-3-ol-protein interactions to modulate 
biological activities has been subject of several investigations (Table 6). Effect of co-





in vivo. Addition of milk to both black and green tea did not decrease plasma antioxidant 
activity in humans (Leenan et al. 2000).  Similarly chlorogenic acid in coffee was bound 
to dairy proteins without causing a significant effect on beverage antioxidant power. 
Incidentally, interactions were found to decrease during in vitro digestion suggesting 
release of phenolic compounds during normal digestion (Dupas et al. 2006a). However, 
addition of milk to black tea (10%) blunted the ability of tea to improve flow mediated 







Table 6: Impact of milk addition to beverages on bioactivity. 














Human, in vivo, 
blueberry with 
milk 
250mg 6.4g No effect - - - Serafini et al. 2009 
Human, in vivo, 
green, black tea 
with milk 
640 and 140 mg for 
green and black tea, 
respectively 
2.0g No effect - - - Leenan et al. 2000 
Human, in vivo, 
black tea with 
milk 
450μmol 1.6g - Decrease - - Lorenz et al. 2007 
Human, in vivo, 
black tea with 
milk 
450μmol 1.6g - Decrease - - Lorenz et al. 2009 




0.05mg/mL 6-12ug/mL - - Decrease - He et al. 2006 
in vitro, oolong 
tea polyphenols, 
pancreatic lipase 










- Tagliazucchi et al. 2005 





5, 50, and 
50μg/mL, 
respectively 
- - Decrease - Naz et al. 2011 
Mouse, in vivo, 
EGCG 0.32% - - - - Decrease 
Grove et al. 
2011 
Rat, in vivo, tea 
flavan-3-ols 1% - - - - Decrease 
Unno et al. 
2009 
in vivo, green tea 





Flavan-3-ol-protein interactions are believed alter macronutrient digestibility and 
availability (Table 6). Addition of green tea flavan-3-ols (mostly galloylated) at 1% w/w 
in diet significantly decreased body weight and increased fecal starch, protein, and lipid 
excretion in Wistar rats (Unno 2009). Similarly, decreased weight gain was observed in 
C57bl/6J mice fed a high fat diet formulated with 0.32% EGCG for 6 weeks compared to 
those fed matching diets void of EGCG. Furthermore, EGCG significantly increased 
fecal lipid content in vivo and competitively inhibited pancreatic lipase activity with 50% 
inhibition at 7.5μl/l in vitro (Grove et al. 2012). These data suggest that tea flavan-3-ols 
inhibit pancreatic lipase decreasing lipid absorption and concurrent weight gain. Not 
surprisingly, these interactions have stimulated interest in tea flavan-3-ols as anti-obesity 
agents.   
Inhibition of specific digestive enzymes by flavan-3-ols has been studied 
extensively (Table 6). Percent inhibition of α-amylase, pepsin, trypsin, and lipase by 0.05 
mg/mL tea derived flavan-3-ols was 61, 32, 38, and 54%, respectively (He et al. 2006). 
Similar results were reportedby Nakai et al. 2005 investigating effects of oolong tea 
polyphenols (monomeric and polymeric flavan-3-ols) on pancreatic lipase. Inhibition by 
polyphenols was attributed to presence of galloyl moieties and polymerization of flavan-
3-ols, suggesting direct but non-specific binding as a primary mechanism. On the other 
hand, resveratrol, quercetin, EGCG, and flavan-3-ol increased initial velocity of pepsin 
activity during digestion of different substrates (Tagliazuchhi et al. 2005).  
There is limited information on the mechanism behind polyphenol-digestive 
enzyme interactions. It appears conformational changes in digestive enzymes as a result 





For example, binding of chlorogenic and caffeic acid to α-amylase altered the 
environment of the enzyme active site, thus causing inhibition of the enzyme 
(Raghavendra et al. 2007). Also, it appears that the high electron density of 
flavonols/flavones compared to flavan-3-ol/flavanones increases binding to digestive 
enzymes through stronger π-π interactions (Lo Piparo et al. 2008).  
Interestingly, in vitro evidence suggests that the interactions of flavan-3-ols with 
digestive enzymes in the gut lumen may be modified by presence of food or salivary 
proteins.  As described previously, proline-rich salivary proteins may also interact with 
EGCG, stabilizing it to digestion and also reducing its inhibitory effect on digestive 
enzymes (Naz et al. 2011). This experiment would seemingly support the notion that the 
astringent response derived from polyphenol interactions with salivary proteins would 
result in protection against anti-nutritional activities of polyphenols against digestive 
enzymes.  
 
1.6.3 Milk Mineral-Milk Protein and –Polyphenol Interactions 
1.6.3.1 Milk Mineral-Milk Protein Interactions 
Milk and its products are used as ingredients in food applications for their 
nutritional and functional properties. Functional properties of milk and milk products 
including gelation, viscosity, emulsification, and foaming are largely attributed to type 
and amount of proteins present and interactions of proteins with milk components. Milk 
minerals constitute about 8-9 g/L of milk and are present as free ions and in complexes 





Solubility of milk protein-milk mineral complexes is important for protein functionality 
including properties such as emulsification, gelation and foam formation/stabilization 
(Swaisgood 1992).  Additionally, these interactionas are believed to impact nutritional 
quality by modulating in vivo absorption and bioavailability of both proteins and minerals 
(Sanyal et al. 1992; Lönnerdalet al. 1994). Impact of milk mineral interactions with 
caseins and β-LG on protein structure and functionality has been subject of many reviews 
(Vegarud et al. 2000; McMahon & Oommen 2008; Gaucheron 2005; Augustin 2000).  
Casein micelles in bovine milk are comprised of four proteins: αs1- casein, αs2- 
casein, β- casein, and κ-casein (Farrell et al. 2006). These caseins can interact with 
themselves, each other, and with minerals (ie. ionic calcium, calcium phosphate) to form 
a meta-stable supramolecular structure. Calcium bridging is an important interaction 
involved in formation of casein micelles in milk. Calcium phosphate nanoclusters appear 
to form interlocking sites between phosphoserine residues of multiple αs- and β-caseins, 
termed “calcium bridges” (Holt et al. 1996) that provide structure-forming points for 
micelle formation (Holt et al. 2003). Cation binding capacity decreases with decreased 
phosphoserine content and is greatest for αs2, followed by αs1, β, and κ-casein (Holt, 
1992). Following initial calcium cross-bridging, hydrophobic regions of caseins orient 
toward other proteins, forming linkages through non-covalent hydrophobic and 
electrostatic interactions. Further calcium bridging occurs through carboxylate and 
phosphoserine side chains of other caseins (Swaisgood 2003; Sood et al. 2002). The final 
casein micelle is a colloidal particle comprised of thousands of casein proteins and 





Manipulation of minerals and mineral salts in dairy products results in altered 
protein functionality that may either improve or dimish the product’s suitability for 
specific food applications. For example, milk with increased soluble calcium required 
increased heating time to coagulate (Kelly et al. 1982). In addition, increased calcium 
concentration promoted aggregation of rennetted micelles, promoting gel formation 
(Zoon et al. 1988; Udabage 1999). However, addition of calcium precipitated αs or β-
casein based emulsions presumably due to shielding of casein negative charges 
(Dalgleish 1987).  
β-lactoglobulin is another milk protein that interacts with milk minerals. Simons 
et al. 2002 investigated the mechanism behind β-lactoglobulin-milk protein interactions 
through a series of tests including calcium-binding measurements, a combination of 
protein chemical modifications, and aggregation studies. Interestingly, they concluded 
that interactions occur due to screening of surface charges on β-lactoglobulin and 
subsequent decrease in electrostatic repulsion leading to aggregation, rather than due to 
formation of calcium bridges.  
Many studies show that calcium enhances heat-induced aggregation of β-
lactoglobulin (Anema & McKenna 1996; Changani et al. 1997; Sherwin & Foegeding 
1997; Xiong et al. 1993). This property is useful for gelling applications. For example, 
microgels were developed by heating β-lactoglobulin witch calcium. For this application, 
amount of calcium required for gel formation decreased with decreasing pH, indicating 
that net charge density of the protein was crucial in microgel formation (Phan-Xuan et al. 





during high temperature short time processing, therefore causing fouling of heat 
exchanges during milk processing. 
 
1.6.3.2 Milk Mineral-Polyphenol Interactions 
In addition to their interactions with proteins, many minerals in solution are well 
documented to interact with flavan-3-ols in both model and complex food systems. 
Mineral-flavan-3-ol interactions have been a subject of several investigations due to 
concerns surrounding their impact on mineral solubility and bioavailability. For example, 
the water-soluble fraction from olives contained polyphenol-bound magnesium (Yaşar & 
Güçe 2004). Similarly, concentration of intact phenolic compounds recovered from 
brewed herbal infusions was lower from tea infusions prepared with mineral water 
containing calcium and magenesium compared to with Milli-Q-quality water and tap 
water (Riehle et al. 2012), suggesting formation of mineral-flavan-3-ol complexes in 
polyphenol rich beverages prepared with mineral rich water. This complex formation has 
been associated with a phenomenon known as ‘tea cream’ that occurs in cooled black tea. 
Tea cream has been attributed to interaction between caffeine and phenolic compounds or 
self-association between phenolic compounds (Roberts et al. 1963; Jöbstl et al. 2005). 
Furthermore, addition of calcium to black tea enhanced self-association of caffeine, 
polyphenols, and therabugins and thus increased creaming, while addition of the 
chelating agent ethylendiaminetetraacetic acid (EDTA) decreased cream formation 
(Jöbstl et al. 2005; Smith 1989). Jackson and Lee 1988 discovered tannase, a polyphenol 





instant black tea, supporting the notion that break down of complex polyphenols would 
reduce formation of mineral-polyphenol complexes. Further, calcium and magnesium 
bioaccessibility from tea-biscuits was negatively correlated with polyphenol content, 
suggesting formation of insoluble polyphenol-mineral complexes that survive through 
simulated digestion.  
Analysis of black tea stain formation on porcelain surface revealed a possible 
calcium-polyphenol interaction mechanism. Polymerization of polyphenols by oxidative 
reactions occurred during stain formation. Addition of calcium ions increased amount of 
stain and addition of EDTA was effective in removing black tea stains suggesting that 
calcium bridging between polyphenols may be involved in stain stability. Results from IR 
analysis (Yamada et al. 2007) suggest that calcium complexation with polyphenols 
occurs by either two hydroxyl groups within catechols or by calcium bridging formations 
between multiple catechols. From these results, it appears that minerals interact strongly 
with polyphenols and flavan-3-ols specifically through electrostatic interaction.  There 
appears to be similarity between these interactions and those with proteins in that they 
have the ability to bind and form bridges between polyphenols.  These similarities and 
potential for competitive interactions between milk protein, minerals and flavan-3-ols, it 
becomes important to consider presence and influence of milk minerals when 
investigating milk protein flavan-3-ol interactions.  This has not been the case in many 
previous studies and has made interpretation of literature difficult.  Additional insight in 
these interactions is needed in order to better understand the potential impact of milk 





1.7 Conclusions and Research Objectives 
In summary, a growing body of evidence supports the notion that polyphenol rich 
foods such as green tea can decrease risk of several chronic and degenerative diseases.  
Tea derived flavan-3-ols have been reported to have modifying activities against 
cardiovascular disease, cancer, diabetes, and cognitive impairment (Hooper et al. 2008; 
Miura et al 2000; Weseler et al. 2011; Wang et al. 2007; Hung et al. 2004; Zhong et al. 
2001; Bonner et al. 2005; Ng et al. 2008; Kuriyama et al. 2006; Hu et al. 2007). However, 
bioavailability of flavan-3-ols is generally low.  A key aspect of this poor bioavailability 
may be related to accessibility of flavan-3-ols to intestinal tissues for absorption 
(bioaccessibility).  While instability of flavan-3-ols to digestive conditions has been 
previously documented to be a primary factor limiting bioavailabilitry (Yoshino et al. 
1999; Zhu et al. 2002a; Green et al. 2007; Neilson et al. 2007; Ferruzzi et al. 2010), less 
is known regarding the extent to which protein-flavan-3-ol interactions may alter stability 
or bioaccessibility of flavan-3-ols.  While a large portion of tea is currently formulated 
with milk, only a few studies have evaluated effects of milk proteins on green tea flavan-
3-ol digestive stability and bioavailability. Interestingly, the physico-chemical nature of 
flavan-3-ol-protein interactions has been subject of several investigations that have 
yielded conflicting results regarding the nature and physiological consequences of such 
associations.  A key component to these conflicting results may involve a more detailed 
consideration of the role of minerals in milk protein-flavan-3-ol interactions.  Additional 
insight into nature and consequences of these interactions between milk protein, milk 
minerals and flavan-3-ols is required to leverage potential effects for optimal delivery of 





The overall objective of this project is to develop a detailed understanding of the 
interaction between tea flavan-3-ols, milk proteins and milk minerals in model beverage 
systems. Specifically, we build on current knowledge of the nature of these interactions 
by assessing in a controlled fashion the comparative binding, stability and 
bioaccessibility of tea flavan-3-ols in model beverages. Our central hypothesis is that 
flavan-3-ol-protein interactions will increase digestive stability and bioaccessibility of 
flavan-3-ols through non-specific binding interactions with individual milk proteins in 
digestive environments. We further expect that these interactions may be altered by 
presence of milk minerals and that flavan-3-ol binding would modify protein digestibility 
and by extension release of flavan-3-ols in the digestive environment.  Understanding 
how these interactions can alter digestive behavior of flavan-3-ols will lead to 
development of strategies that facilitate inclusion of flavan-3-ols in food and beverage 
system with improved stability and bioavailability. 
 
To achieve our overall objectives, the following specific aims are proposed: 
 
Specific Aim 1: Determine the impact of milk mineral and milk protein interactions 
on stability of flavan-3-ols in beverage systems and in the digestive environment. A 
three stage in vitro digestion model was utilized to assesss the impact of green tea 
formulation with milk proteins and a milk mineral buffer solution on digestive stability of 
flavan-3-ols. Our working hypothesis was that the nature of flavan-3-ol-protein 
interaction will be dependent on both protein, presence of milk minerals and flavan-3-ol 





of proteins in the food matrix. Binding with protein would lead to enhanced oxidative 
stability of flavan-3-ols through the digestive environment and thus higher digestive 
recovery.  
 
Specific Aim 2: Characterize protein profile of individual milk protein digests 
resulting from in vitro digestion by pepsin and pancreatin. SDS-PAGE was utilized to 
evaluate protein degradation. Our working hypothesis was that each milk protein would 
be rapidly degraded due to large amount of digestive enzymes used in this study. 
 
Specific Aim 3: Assess potential for binding between individual milk proteins 
digested to various extents and intact EGCG. Fluorescence spectroscopy was utilized 
to measure quenching of protein fluorescence by EGCG. Our working hypothesis was 
that binding of EGCG to milk protein is altered by degradation of protein. Binding data 







CHAPTER 2. MATERIALS AND METHODS 
2.1 Chemicals and Standards 
Acetonitrile, acetic acid, methanol, water (Mallinckrodt-Baker, Phillipsburg NJ), 
and formic acid (Sigma-Aldrich St. Louis, MO) used in HPLC analysis were certified 
HPLC and ACS grade. Urea (U5378), uric acid (U2625), porcine mucin (M2378), α-
amylase (A3176), pepsin (P7125), lipase (L3126), pancreatin (P1750), and bile salt 
(B8631) extract utilized for in vitro digestion were purchased from Sigma. KH2PO4 
(VWR), K2SO4 (Riedel-de Haën), potassium citrate, sodium citrate, KCl, CaCO3, and 
MgCO3 (Sigma-Aldrich) used in milk salt solution (JK) (Jenness & Koops, 1962) and 
Tris-HCl for fluorometry were purchased from Sigma-Aldrich. NaCl, HCl, and NaHCO3 
were purchased from Mallinckrodt (Phillipsburg, NJ). Powdered green tea extract (GT) 
was a gift from Nestlé PTC, Marysville, OH, USA. Acid precipitated casein was a gift 
from Kerry Group (Beloit, WI) (Figure D.1), and α-lactalbumin (α-LA) and β-
lactoglobulin (β-LG) were purchased from Sigma. Nonfat dry milk (NFDM) was Saco 
brand Mix 'n Drink. Coomassie Brilliant Blue R-250 for SDS-PAGE was purchased from 
Bio-Rad. Acrylamide, sodium thiosulfate, and tetramethylethylenediamine for SDS-






2.2 Preparation of Protein and Oral Phase Solutions for in vitro Digestion 
Buffer (JK) for protein solutions was prepared following a procedure by Jenness & 
Koops, 1962. Specifically, KH2PO4, potassium citrate·H2O, sodium citrate·5H2O, K2SO4, 
CaCO3, MgCO3, and KCl, were dissolved in double distilled water (dd water) and pH 
adjusted to pH 6.3 with KOH to final concentrations of 1.58, 1.2, 2.12, 0.18, 1.32, 0.65, 
0.3, 0.6, and 2.25 g/L KH2PO4, potassium citrate·H2O, sodium citrate·5H2O, K2SO4, 
CaCl2·2H2O, MgCl2·6H2O, K2CO3, KCl, and KOH respectively. Solutions containing 
individual milk proteins were formulated to mimic concentrations naturally occurring in 
milk. Sodium caseinate (S-CSN) was prepared in both dd water and JK by slowly stirring 
acid precipitated casein into solution for 2 hr, maintaining a pH of 6.3 by addition of 1.0 
M NaOH. The final concentration of the solution was 35.6 mg/mL sodium caseinate. β-
LG and α-LA solutions were prepared in JK similarly; however solutions were stirred for 
only 5 min.  Final concentrations of β-LG and α-LA in JK were 3.5 and 1 mg/mL protein, 
respectively. NFDM was prepared in dd water (10% w/w). Oral phase solution was 
prepared by addition of KCl, Na3PO4, Na2SO4, NaCl, and NaHCO3 for final 
concentrations of 242.78, 10.83, 8.03, 10.20, and 40.33 mmol/L, respectively. 
 
2.3 Model Tea Beverage Preparation 
GT was dissolved in dd water (3 mg/mL).  The flavan-3-ol composition of the tea 
powder is described in Table 7.  Test solutions with tea were designed to deliver 0.60 
mg/ml of total tea flavan-3-ols (0.18, 0.032, 0.33 and 0.054 mg/mL of EGC, EGCG, EC 
and ECG respectively). The flavan-3-ol content was equivalent to that found in ~0.5-1 





and 40% (v/v) of aforementioned protein solutions matching tea powder free controls (dd 
water, JK) were prepared. 
 
Table 7: Flavan-3-ol content in green tea powder. 
Flavan-3-ol mg/g tea extract 
powder 
EGC 60.31 ± 1.29 
EC 10.86 ± 0.77 
EGCG 110.05  ± 2.35  
ECG 17.85  ± 0.33  
 
 
2.4 Three Stage in vitro Digestion of Model Tea Beverages 
Aliquots of freshly prepared tea beverages were subjected to simulated oral, gastric 
and small intestinal digestion in sequence as previously described by Thakker et al. 2007 
modified by Kean et al 2011.  Briefly, 6 mL oral phase solution was added to the 
formulated beverages (20 mL) described above. The reaction tube was vortexed briefly to 
ensure mixing, blanketed with nitrogen, and incubated in a covered shaking water bath 
(37°C, 85 opm, 10 min). Samples were then diluted to 30 mL with saline. The gastric 
phase was initiated by addition of 2 mL porcine pepsin solution (20 mg/mL in 0.1 M HCl) 
and adjustment of the pH to 3.0 ± 0.1 with 1.0 M HCl. After addition of saline for 40 mL 
total solution, samples were blanketed with nitrogen and incubated in a covered shaking 
water bath (37°C, 85 opm, 1 hr). The small intestinal phase was initiated by addition of 
1.0 M NaHCO3 to raise the pH of gastric digesta (GD) to 6.5 ± 0.1.  A cocktail of small 





lipase in 0.1 M NaHCO3) as well as porcine bile salts (3 mL, 120 mg/mL bile extract in 
0.1 M NaHCO3). The pH was then readjusted to 6.5 ± 0.1 with 1.0 M HCl and saline was 
added for 50 mL total solution. Samples were then blanketed with nitrogen and incubated 
in a covered shaking water bath (37°C, 85 opm, 2 hrs). After completion of the small 
intestinal phase, samples were centrifuged (10,400 x g, 4°C, 1 hr).  Aliquots of 
undigested beverage starting material (SM), GD, and centrifuged aqueous small intestinal 
digesta (DG) were collected and acidified with 2% aqueous acetic acid (1:1) and stored 
frozen at -80°C under a blanket of nitrogen until analysis by HPLC. 
 
2.5 Flavan-3-ol Analysis by HPLC 
Thawed aliquots of SM tea-protein beverages were extracted prior to analysis 
following an enzyme-assisted extraction previously reported (Ferruzzi & Green 2006). 
Aliquots from DG and extracted SM were diluted 1:1 with 2% acetic acid in dd water and 
centrifuged at 14,000 x g for 5 minutes. Supernatants from both SM and DG were 
collected and filtered through a 0.45 μm PTFE filter prior to analysis. 10 μL of 
resolubilized sample was injected on an HP 1050 HPLC system equipped with a 12 
channel CoulArray Multi-channel ECD Array system (ESA Inc). Separation was 
achieved according to Peters et al. (2010) with minor modification. A Waters Xterra RP-
C18 column (3.9 mm id x 100 mm, 3.5 μM particle size) preceded by a guard column 
packed with the same stationary phase was used to separate flavan-3-ols under gradient 
conditions at a flow rate of 0.8 mL/min using a binary mobile phase of ddH2O, 
acetonitrile, formic acid (91.9:8:0.1) in reservoir A and ddH2O, acetonitrile, methanol, 





followed by a linear gradient to 50:50 A/B (0-5 min), 10:90 A/B (5-7 min), 10:90 A/B (7-
10 min), 90:10 A/B (10-12 min), and 90:10 A/B (12-15 min). 12-channel ECD was 
performed with cell potentials at -100, 120, 180, 240, 300, 360, 420, 480, 540, 600, 660, 
and 720 mV. Flavan-3-ols were quantified by summing responses obtained at 120, 180, 
240, and 300 mV (channels 2-5). 
 
2.6 Assessment of Protein-Flavan-3-ol Interactions Through in vitro Digestion 
2.6.1 In vitro Digestion of S-CSN, β-LG, and α-LA for Assessment by SDS-PAGE 
S-CSN, β-LG, and α-LA were digested in vitro for analysis by SDS-PAGE. To 
obtain simple digests for clean SDS-PAGE analysis, digestions were carried out such that 
only target protein, JK buffer, saline, pepsin, and pancreatin were present in final digests. 
Digestions were completed in quadruplicate representing gastric times 0 and 1 hour, and 
duodenal times 15, 30, 60, and 120 mins. Beverages (5.6 mL) containing protein (35.6 
mg/mL acid casein, 1 mg/mL α-LA, or 3.5 mg/mL β-LG in JK) were mixed with 0.9% 
saline for 8.4 mL total solution. The pH was adjusted to 3.0 ± 0.1 using 1.0 M HCl 
followed by addition of pepsin solution (0.56 mL, 20 mg/mL) to simulate the gastric 
phase. Gastric time 0 (G0) samples were frozen (-20°C), and freeze-dried for analysis. 
Remaining samples were standardized to 11 mL, blanketed with nitrogen gas, parafilmed, 
and incubated in a water bath (85 opm, 1 hr, 37°C). After incubation, gastric time 1 hour 
(G1) samples were frozen (-20°C) and freeze-dried for analysis. Remaining samples were 
adjusted to pH 6.5 ± 0.1 using 1.0 M NaHCO3. Pancreatin solution (0.56 mL, 30 mg/mL) 
was added to simulate the duodenal phase, the pH was readjusted to 6.5, saline was added 





incubated in a water bath (85 opm, 37°C) for 15, 30, 60, and 120 minutes. Duodenal 
samples (D15, D30, D60, D120) were collected, frozen (-80°C), and freeze-dried for 
analysis. 
 
2.6.2 SDS-PAGE Analysis for Characterization of Milk Protein Digests 
Raw material (α-LA, β-LG, S-CSN, pancreatin and pepsin) and freeze-dried digests 
were characterized by SDS-PAGE using a Bio-Rad Mini-PROTEAN Tetra cell (BioRad 
Laboratories, California, USA) using hand-casted gels (Gravel 2002). 10-20% 
polyacrylamide gels were utilized for separation of proteins from raw materials and S-
CSN and β-LG digests. A 10% polyacrylamide gel was utilized for separation of protein 
from α-LA digest. Freeze-dried samples from in vitro digestion of S-CSN, α-LA, and β-
LG were resolubilized in 10 mL, 280 μL, and 1 mL, respectively, of Tris-HCl (10 mM, 
pH 7.4) for about 8 mg/mL protein total in sample. Samples were mixed 1:1 with Bio-
Rad 2x Laemmli buffer and boiled for 5 minutes before application onto gel. The gels 
were stained using 2% Coommassie Blue solution and destained (Gravel 2002). 
Molecular weights were estimated using a Bio-Rad broad range molecular weight marker 
calibration kit (6,500 to 200,000 Da) for raw materials and S-CSN and β-LG digests, and 
a Precision Plus Protein™ Kaleidoscope™ Standards calibration kit (10,00 to 250,000 Da) 





2.6.3 Evaluation of Milk Protein-EGCG Interactions through Fluorescence 
Spectroscopy 
 
The in vitro digestion procedure used prior to analysis by SDS-PAGE (outlined in 
section 2.6.1) was used with minor modification to digest S-CSN for fluorescence 
analysis to determine extent of protein Trp fluorescence quenched by EGCG at various 
points of digestion.  S-CSN (0.023 g/L) was prepared in Tris-HCl (10 mM, pH 7.4) and 
pH adjusted with NaOH to pH 6.3. Final digesta contained 0.0115 mg/mL S-CSN, 0.005 
mg/mL pepsin, and 0.006 mg/mL pancreatin and had final pH of 3.0 or 6.5 for gastric and 
duodenal digesta, respectively. According to preliminary results (See Appendix B), 
aforementioned concentrations are appropriate to ensure S-CSN fluorescence is within 
linear range of fluorometerand digestive enzyme Trp fluorescence interferes minimally 
with S-CSN fluorescence. Gastric time zero (G0) samples were prepared by addition of 1 
mL pepsin solution (0.07 mg/mL in 0.1 M HCl) and 1 mL pancreatin solution (0.084 
mg/mL in 0.1 M NaHCO3) to 7 mL S-CSN solution. G0 samples were standardized to 14 
mL with Tris-HCl pH 3.0, pH adjusted to 3.0, and frozen (-20°C). For remaining samples, 
S-CSN (7 mL) was pH adjusted to 3.0 ± 0.1 by addition of 1.0 M HCl and made up to 
8mL with saline. Subsequently, the gastric phase was initiated by addition of 1 mL pepsin 
solution (0.07 mg/mL in 0.1M HCl) and samples were blanketed with nitrogen gas and 
incubated in a shaking water bath (85 opm, 37°C, 1 hr).Pancreatin (1 mL, 0.084 mg/mL 
in 0.1 M NaHCO3) was then added to gastric time one hour (G1) samples which were 
made up to 14 mL with Tris-HCl pH 3.0, pH adjusted to 3.0, and frozen (-20°C). The 





addition of 1mL pancreatin (0.084 mg/mL in 0.1 M NaHCO3). Samples were then 
readjusted to pH 6.5 ± 0.1, made up to 12 mL with saline, blanketed with nitrogen gas 
and incubated in a shaking water bath (85 opm, 37°C). Digestions were stopped at either 
15, 30, 60, or 120 mins (D15, D30, D60, D120), made up to 14 mL with Tris-HCl pH 6.5, 
pH adjusted to 6.5, and frozen (-20°C).   
Additional experiments using S-CSN as a milk protein model were executed to 
determine (1) extent of binding between EGCG and digestive enzymes and (2) S-CSN-
EGCG binding effects due to digestive pH. For both experiments, the digestion procedure 
outlined in the previous paragraph was mimicked with minor changes (Table 8). Extent 
of binding between EGCG and digestive enzymes was determined by incubating pepsin 
and pancreatin at pH 3.0 and/or 6.5 without S-CSN prior to fluorometry. To determine S-
CSN-EGCG binding effects due to digestive pH, S-CSN was incubated at pH 3.0 and/or 





Table 8: Experimental conditions of digestions preceding fluorescence spectroscopy used 
to determine (1) extent of binding between EGCG and digestive enzymes, (2) S-CSN-
EGCG binding effects due to digestive pH and (3) combined effect of protein digestion, 
pH, and presence of enzymes in S-CSN digesta on fluorescence quenching of protein Trp 







Fluorometric experiments were carried out on a Perkin-Elmer LS55 Spectrometer 
(Woodbridge, ON, Canada). Method development was initiated following a method by 
Kanakis et al. 2011.  
An EGCG stock solution (12 µM in Tris-HCl (10 mM, pH 3.0 or 6.5)) was 
prepared and kept on ice for analysis. EGCG was stable under these conditions with 98% 
recovery over 6 h.  S-CSN digested to various extents in vitro wasmixed 1:1 with EGCG 
by inverting solution 10 times. EGCG concentration of each solution was about 6 µM, 
and protein concentration of S-CSN was 0.0115 g/L. Pepsin and pancreatin were also 
present from background digestion enzyme mixes at 0.005 and 0.006 mg/mL, 
respectively, therefore, blanks containing milk protein and background digestive enzyme 
mix mixed 1:1 with Tris-HCl (10 mM, pH 3.0 or 6.5) replacing EGCG were prepared. 
Fluorescence spectra were obtained using λexc=280nm and λemi from 290-500nm. 














solution for  
fluorometry 
(1) EGCG-enzyme  No Yes 3.0 6.5 
(2) pH  Yes No 3.0 6.5 





Percentage fluorescence quenched was calculated using the following formula: 
 
%Fq=[(F0-F)/F0]100  
Where: F0= initial fluorescence intensity (intensity of blank) 
F= fluorescence intensity in presence of quenching agent  
 
Preliminary tests showed that EGCG mixed 1:1 with Tris-HCl (buffer) fluoresced 
less than just Tris-HCl (Table C.1). In addition, it appeared EGCG quenched digestive 
enzyme fluorescence. Due to its low impact on fluorescence and ability to quench some 
enzyme fluorescence, EGCG fluorescence was not corrected for in calculations for 
percent quenching of Trp residues by EGCG. 
 
2.7 Data Analysis 
Results calculated from LC-ECD data include both relative and absolute 
bioaccessibilities of EGC, EC, EGCG, and ECG from each beverage. Bioaccessibility is 
a measure of the digestive release and stability of a compound in the gut and is required 
for the compound’s subsequent absorption. Relative bioaccessibility is defined as the 
percent of flavan-3-ol recovered in final digesta relative to that in starting material. 
Absolute bioaccessibility is the amount of flavan-3-ol available for absorption defined as 
the relative bioaccessibility multiplied by grams of starting material and provides 
information on impact of changes in digestive recoveries of each flavan-3-ol relative to 
their abundance in GT. Percentage fluorescence quenched (%Fq) is the ratio of amount of 





original protein fluorescence. Increased %Fq suggests increased quencher binding to Trp 
residues. SDS-PAGE was used to separate peptides resulting from digestion of individual 
proteins. Protein bands were compared to molecular weight ladder (6.5-200 kDa for S-
CSN and β-LG digests, 10-250 kDa for α-LA digests). Fading of bands and appearance 
of lower molecular weight bands with increasing extent of digestion suggest degradation 
of protein or peptide to smaller peptides. In vitro digestion and fluorometry data represent 
mean +/- standard error of the mean of four individual samples. Analysis by one-way 
ANOVA was performed using SAS 9.3 (SAS Institute, Cary, NC) for each variable and 
control. Significant differences between treatments were evaluated by a Bonferroni 










CHAPTER 3. RESULTS 
Consequence of milk addition on bioaccessibility and bioavailability of green tea 
flavan-3-ols has been previously investigated using both in vivo and in vitro models.  
Although results are conflicting between botanical matrices and approaches, there 
appears to be consensus that there is potential for milk protein interaction to alter 
bioaccessibility of tea flavan-3-ols in the gastrointestinal (GI) tract (Xie et al. 2012; 
Green et al. 2007; van der Burg-Koorevaar et al. 2011) (Section 1.6.2.3, Table 5). 
However, extent of this effect and putative involvement of individual milk proteins in 
such interactions remain unclear. Additionally, many previous studies did not addresss 
the role of milk minerals to modulate flavan-3-ol digestive stability or capacity for 
protein binding.  The purpose of this study was therefore to investigate extent to which 
tea derived polyphenols (the flavan-3-ols) interact with specific milk proteins (α-LA, β-
LG, S-CSN), at relevant beverage concentrations and to determine the impact of these 
interactions on digestive stability and bioaccessibility of green tea flavan-3-ols in an in 
vitro three-stage gastrointestinal model.  
There was no significant difference (p>0.05) in flavan-3-ol bioaccessibility between 
green tea beverages formulated with 10, 20, and 40% of test material (Figures A.1, A.2, 
A.3, and A.4 in Appendix). Therefore, results and discussion will be based on relative 





As mentioned above, absolute bioaccessibility will be discussed to provide 
information on the impact of changes in digestive recoveries of each flavan-3-ol relative 
to their abundance in GT. 
 
3.1 Starting Flavan-3-ol Profile of Green Tea Extract Beverages 
Starting levels (SM) of total flavan-3-ols ranged from 42.16 to 57.52 
μmol/digestion reaction (50 mL of model tea beverage) (Table 9). Beverages formulated 
with NFDM had significantly lower (p<0.05) total flavan-3-ol level compared to 
beverages formulated with JK control and α-LA, β-LG, and S-CSN solubilized in JK: 
42.16±0.36 μmol of total flavan-3-ols per reaction compared to 52.18±0.20, 52.21±0.68, 
49.05±0.77, and 57.52±1.90 μmol of total flavan-3-ols per reaction respectively. In 
addition, SM level of total flavan-3-ols in beverages formulated with S-CSN in buffer (S-
CSN/JK) was significantly higher (p<0.05) compared to S-CSN in dd water (S-
CSN/water) and dd water controls with 57.52±1.90 compared to 48.56±0.61 and 
46.33±2.19 μmol/digestion reaction respectively. No further differences in SM total 





Table 9: Total flavan-3-ols in undigested model beverages (starting material-SM) and 
digested model beverages (digesta-DG).Presence of different letters in same column 
indicates significantly lower flavan-3-ol content between formulations. 
Treatment 
Total Flavan-3-ols in 
SM (μmol/digestion 
reaction) 
Total Flavan-3-ols in 
DG (μmol/digestion 
reaction) 
NFDM 42.16 ± 0.36a,b 15.32 ± 0.38 a 
JK Control 52.18 ± 0.20 a,c 16.86 ± 0.66b 
α-LA 52.21 ± 0.68 a 13.90 ± 0.74 a 
β-LG 49.05 ± 0.77 a 14.48 ± 0.28 a 
S-CSN in JK 57.52 ± 1.90b 5.91 ± 0.45b 
dd Water Control 48.56 ± 0.61 a,c 8.64 ± 0.50b 







Table 10: Bioaccessibility (% and μg/g) of (a) EGC, (b) EC, (c) EGCG, and (d) ECG 
from green tea beverages formulated with non-fat dry milk, buffer, water; α-LA, β-LG 
and S-CSN/buffer; and S-CSN/water. Presence of different letters in same column 
indicates significantly lower flavan-3-ol content between formulations. 
 









Non-Fat Dry Milk 13.54 ± 0.09a 9.72 ± 0.25a 71.9 ± 1.4e 141.6 ± 2.7c 
JK Control 15.92 ± 0.08a 7.90 ± 0.64a 49.9 ± 4.7a 98.3 ± 9.2a 
α-LA 15.71 ± 0.26a 7.12 ± 0.47a 45.5 ± 2.8a,b 89.6 ± 5.6a 
β-LG 15.49 ± 0.38a 8.44 ± 0.25a 54.7 ± 0.3a,e 107.6 ± 0.6a,c 
S-CSN/JK 15.67 ± 0.76a 1.40 ± 0.42b,c 9.1 ± 2.4c 17.8 ± 4.7b 
Water Control 15.01 ± 0.23a 4.08 ± 0.49b 30.2 ± 0.9b,c 59.4 ± 1.8b 
S-CSN/Water 11.35 ± 1.55b 0.86 ± 0.24c 6.8 ± 1.0d 13.5 ± 2.0b 









Non-Fat Dry Milk 3.70 ± 0.03c 2.53 ± 0.09b 68.7 ± 2.9c 25.7 ± 5.7b 
JK Control 4.53 ± 0.02a,b 3.73 ± 0.06a 82.6 ± 1.4a 30.9 ± 0.5a 
α-LA 4.21 ± 0.21a 3.34 ± 0.15c 79.7 ± 2.0a 29.8 ± 3.9a 
β-LG 4.39 ± 0.11a,b 2.73 ± 0.08b,c 62.8 ± 2.9b,c 23.5 ± 5.6b 
S-CSN/JK 4.76 ± 0.04b 2.74 ± 0.01b,c 58.1 ± 0.6b 21.7 ± 1.2b 
Water Control 4.15 ± 0.07a,c 2.55 ± 0.03b 61.3 ± 1.1b,c 22.9 ± 2.3b,c 
S-CSN/Water 4.46 ± 0.12a,b 3.00 ± 0.07c 67.9 ± 0.4b,c 25.4 ± 0.8c 









Non-Fat Dry Milk 20.33  ± 0.34c 2.62 ± 0.27c 13.1 ± 1.2c 31.4 ± 2.4a,b 
JK Control 26.42 ± 0.17a 4.41 ± 0.13a 16.9 ± 0.5a 40.5 ± 1.2a 
α-LA 26.64 ± 0.57a,b 2.89 ± 0.54c 10.9 ± 1.8b,c 26.2 ± 3.5b 
β-LG 24.07 ± 0.65a,c 2.81 ± 0.09c 11.9 ± 0.6c 28.6 ± 1.1b 
S-CSN/JK 31.00 ± 1.69b 1.39 ± 0.16b,c 4.7 ± 0.6d 11.3 ± 1.2c 
Water Control 24.13 ± 0.55a,c 1.63 ± 0.08b,c 7.1 ± 0.2b,d 16.9 ± 0.5b 
S-CSN/Water 24.78 ± 1.52a 1.14 ± 0.05b 4.9 ± 0.1d 11.7 ± 0.2b 









Non-Fat Dry Milk 4.59 ± 0.08c 0.46 ± 0.05b 10.9 ± 1.1b 4.4 ± 2.1b 
JK Control 5.30 ± 0.05a,b,c 0.81 ± 0.02a 16.1 ± 0.4a 6.5 ± 0.2a 
α-LA 5.64 ± 0.14a,c 0.55 ± 0.08b 10.4 ± 1.1b,c 4.2 ± 2.2b 
β-LG 5.10 ± 0.14a,b 0.50 ± 0.02b 10.7 ± 0.6b 4.3 ± 1.2b 
S-CSN/JK 6.09 ± 0.39b 0.16 ± 0.02b 7.1 ± 0.6c 2.9 ± 1.2b 
Water Control 5.27 ± 0.12a,b,c 0.39 ± 0.01b 8.1 ± 0.2b,c 3.3 ± 0.4b,c 









Individual tea flavan-3-ols in SM including EGC, EC, EGCG, and ECG ranged 
from 3.7 to 31.0 μmol/digestion reaction (Figures 6 and 8, Table 10). No significant 
difference in individual SM flavan-3-ol level was found between dd water and buffer 
formulations.  For individual flavan-3-ols in NFDM beverages, EC (3.70±0.03 
μmol/digestion reaction) was significantly lower (p<0.05) compared to all treatments 
except dd water; EGCG (20.33±0.34 μmol/digestion reaction) was lower compared to JK 
buffer (p<0.05) and beverages formulated with S-CSN and α-LA (p<0.05); and ECG 
(4.59±0.08 μmol/digestion reaction) was lower compared to beverages formulated with 
S-CSN and β-LG (p<0.05). In addition, SM levels of EGCG in model beverages 
formulated with S-CSN/JK (31.00±1.69 μmol/digestion reaction) were significantly 
higher (p<0.05) compared to all treatments except α-LA. Levels of individual flavan-3-
ols in beverages formulated with JK buffer, α-LA, and β-LG were not significantly 






Figure 6: Levels of (a) EGC, (b) EC, (c) EGCG, and (d) ECG in starting material and 
aqueous digesta of green tea beverages formulated with sodium caseinate in JK buffer or 
dd water and dd water and JK buffer controls. Presence of different letters within raw 
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3.2  Green Tea Flavan-3-ol Bioaccessibility in Milk Mineral Buffer (JK) 
Initial flavan-3-ol levels in model beverage systems (SM) following simulated oral, 
gastric and small intestinal digestion were assessed (Figures 6 and 8, Table 10) to 
determine the impact of milk minerals on flavan-3-ol bioaccessibility. Initial assessment 
focused on the impact of JK buffer relative to dd water on tea flavan-3-ol in vitro 
digestive stability/bioaccessibility.  It appears that presence of milk minerals from JK 
buffer significantly increased digestive stability of flavan-3-ols relative to dd water 
formulation (p<0.05).  
 Total flavan-3-ols levels in JK buffer control final digesta (DG) (16.86±0.66 
μmol/digestion reaction) was significantly higher (p<0.05) than in dd water control DG 
(8.64±0.50 μmol/digestion reaction) (Figure 6, Table 9). Beverages formulated with JK 
buffer had significantly higher (p<0.05) DG levels of EGC, EC, EGCG, and ECG 
compared to dd water control beverage with 7.90±0.64, 3.73±0.06, 4.41±0.13 and 
0.81±0.02 μmol/digestion reaction compared to 4.08±0.49, 4.15±0.07, 1.63±0.08, and 
0.39±0.01 μmol/digestion reaction respectively (Table 10). These levels represent a 
significant increase (p<0.05) in bioaccessibility of all tea flavan-3-ols in beverages 
formulated with JK buffer compared to those formulated with dd water from 30.2±0.9, 
61.3±1.1, 7.1±0.2, and 8.1±0.2% to 49.9±4.7, 82.6±1.4, 16.9±0.5, and 16.1±0.4% for 
EGC, EC, EGCG, and ECG, respectively (Figure 7, Table 10). These values represent 
increases in absolute bioaccessibilities from 59.4±1.8, 22.9±2.3, 16.9±0.5, and 3.3±0.4 
μmol/g for dd water controls to 98.3±9.2, 30.9±0.5, 40.5±1.2, and 6.5±0.2 μmol/g for 







Figure 7: (a) Relative (%) and (b) absolute (μg/g) bioaccesibility of flavan-3-ols from 
green tea beverages formulated with sodium caseinate in dd water or buffer, and dd water 
and buffer controls.Presence of different letters indicates significantly different flavan-3-
ol recovery between formulations. 
 
 
3.3 Green Tea Flavan-3-ol Bioaccessibility in Non-Fat Dry Milk (NFDM) 
Formulations 
Green tea beverages were formulated with NFDM to determine effects of the full 
milk matrix on flavan-3-ol digestive stability and bioaccessibility. Bioaccessibility of 
flavan-3-ols from beverages formulated with NFDM was compared with dd water control 
to parallel past studies concerning bioaccessibility of tea flavan-3-ols from beverages 
formulated with milk/creamer compared to dd water controls. NFDM is obtained by 





























































































































































































































































contained both milk proteins and milk minerals in the same relative proportions found in 
milk. Therefore, NFDM formulations were also compared to JK buffer control to focus 
on impacts of milk protein on flavan-3-ol bioaccessibility while minimizing observations 
of changes in bioaccessibililty due to presence of milk mineral. 
Total flavan-3-ol levels in NFDM DG (15.32±0.38 μmol/digestion reaction) were 
not significantly different (p>0.05) than JK buffer control DG (16.86±0.66 
μmol/digestion reaction), but were significantly higher than dd water control (8.64±0.50 
μmol/digestion reaction) (Table 9). Interestingly, the overall trend for impact on 
individual flavan-3-ol bioaccessibility by formulation of green tea extract beverages with 
NFDM was different depending on whether milk mineral buffer was present (Figure 7, 
Table 10). Flavan-3-ol bioaccessibility generally increased with addition of NFDM 
compared to dd water control, but decreased compared to buffer control. Levels of EGC 
and EGCG in NFDM based beverage DG were 9.72±0.25 and 2.62±0.27 μmol/digestion 
reaction (Figure 6, Table 10) translating to significantly improved (p<0.05) 
bioaccessibilities of EGC and EGCG from NFDM formulations compared to dd water 
control from 30.2±0.9 and 7.1±0.2% (59.4±1.8 μmol/g and 16.9±0.5 μmol/g) to 71.9±1.4 
and 13.1±1.2% (141.6±2.7 and 31.4±2.4 μmol/g), respectively (Figure 7, Table 10). EC 
and ECG were present in NFDM DG at 2.5±0.1 and 0.5±0.1 μmol/digestion reaction 
(Figure 6). Bioaccessibilities of EC and ECG from NFDM formulations were 68.7±2.9% 
(25.7±5.7 μmol/g) and 10.9±1.1% (4.4±2.1 μmol/g), respectively and were not 
significantly different (p>0.05) compared to dd water based tea beverage control (Figure 





Compared to buffer control, bioaccessibility of EGC was significantly (p<0.05) 
higher, increasing from 47.5±3.0% to 71.9±1.4% (98.3±9.2 μmol/g to 141.6 μmol/g) by 
addition of NFDM (Figure 7, Table 10). However relative bioaccessibility of EC, EGCG, 
and ECG were significantly (p<0.05) decreased to 68.7±2.9, 13.1±1.2, and 10.9±1.1% 
from 82.6±1.4, 16.9±0.5 and 16.1±0.4%, respectively, compared to JK buffer controls by 
addition of NFDM (Figure 7, Table 9). In terms of absolute bioaccessibility, EC, EGCG, 
and ECG decreased to 25.7±5.7, 31.4±2.4, and 4.4±2.1 μmol/g from 30.9±0.5, 40.5±1.2, 
and 6.51±0.2 μmol/g, respectively, compared to JK buffer controls by addition of NFDM. 
Although there was no significant difference (p>0.05) in flavan-3-ol 
bioaccessibility from green tea beverages formulated with 10, 20, and 40% of test 
material (p<0.05) (See Appendix Figure A.1), it appears that relative and absolute 
bioaccessibility of EGC from green tea beverages formulated with 40% NFDM 
formulations (71.9±1.4% and 141.6±2.7 μg/g) are higher than formulations containing 10% 
of the test material (57.5±1.4% and 113.2±2.7 μg/g). 
 
3.4 Green Tea Flavan-3-ol Bioaccessbility in Sodium Caseinate (S-CSN), Milk 
Mineral, and Water Formulations 
Effects of S-CSN formulated in dd water and S-CSN formulated in JK buffer on tea 
flavan-3-ols were compared to dd water and JK buffer controls, respectively. In addition, 
differences between S-CSN treatments were investigated to better define the role of 
protein in presence and absence of milk minerals. S-CSN was chosen as a model to 
investigate impact of milk serum on interactions between milk protein and flavan-3-ols 





examination of literature (Arts et al. 2002; Lorenz et al. 2007; Shpigelman et al. 2012; 
Hasni et al. 2011; Kanakis et al. 2011; von Staszewski et al. 2012; Bohin et al. 2012). 
Additionally, S-CSN in JK (S-CSN/JK) formulation was compared to NFDM to 
determine extent to which S-CSN may be responsible for observed NFDM effects. 
Interestingly, flavan-3-ol bioaccessibility from beverages formulated with S-CSN was 
significantly (p<0.05) lower than beverages formulated with NFDM. In regards to impact 
of milk mineral buffer on S-CSN-flavan-3-ol interactions, there appears to be no overall 
effect.  
Total flavan-3-ols level in S-CSN/JK DG (5.91±0.45 μmol/digestion reaction) was 
significantly lower (p<0.05) than JK control (16.86±0.66 μmol/digestion reaction) (Table 
9). S-CSN/JK had significantly (p<0.05) decreased DG levels of each individual flavan-
3-ol compared to buffer control (Figure 6, Table 10). Specifically, levels of EGC, EC, 
EGCG, and ECG in S-CSN/JK DG were 1.40±0.42, 2.74±0.01, 1.39±0.16, 0.16±0.02 
μmol/digestion reaction. Accordingly, relative bioaccessibilities of EGC, EC, EGCG, and 
ECG from beverages formulated with S-CSN/JK were significantly lower (p<0.05) 
compared to JK control decreasing from 49.9±4.7, 82.6±1.4, 16.9±0.5, and 16.1±0.4% to 
9.1±2.4, 58.1±0.6, 4.7±0.6, and 7.1±0.6% (Figure 7, Table 10). In absolute terms, S-
CSN/JK significantly (p<0.05) decreased bioaccessibility of all flavan-3-ols compared to 
JK control from 98.3±9.2, 30.9±0.5, 40.5±1.2, and 6.5±0.2 μmol/g to 17.8±4.7, 21.7±1.2, 
11.3±1.2, and 2.9±1.2 μmol/g respectively for EGC, EC, EGCG and  ECG.  
Total flavan-3-ols level in aqueous S-CSN (S-CSN/water) DG (5.42±0.26 
μmol/digestion reaction) was not significantly different (p>0.05) than dd water control 





CSN/water had significantly lower and higher (p<0.05) DG levels of EGC and EC, 
respectively, compared to dd water control beverages with 0.86±0.24 and 3.00±0.07 
relativeto 4.08±0.49 and 2.55±0.03 μmol/digestion reaction EGC and EC, respectively 
(Figure 6, Table 10). There was no significant difference (p>0.05) in DG levels of EGCG 
and ECG from S-CSN/water formulations (1.14±0.05 and 0.42±0.00 μmol/digestion 
reaction, respectively) compared to dd water control beverages (1.63±0.08 and 0.39±0.01 
μmol/digestion reaction, respectively). In terms of bioaccessibility, S-CSN/water 
significantly decreased (p<0.05) bioaccessibility of only EGC compared to dd water 
control from 30.2±0.9 to 6.8±1.0% (59.4±1.8 to 13.5±2.0 μmol/g), but did not 
significantly (p>0.05) affect bioaccessibility of remaining flavan-3-ols compared to 
control (Figure 7, Table 10).  
Individual flavan-3-ol levels in S-CSN/JK DG were not significantly different 
(p>0.05) from levels in S-CSN/water DG (Figure 6, Table 10). Similarly, relative and 
absolute bioaccessibilities of each flavan-3-ol from S-CSN/JK compared to S-CSN/water 
formulations were not significantly different (p<0.05) (Figure 7, Table 10). Compared to 
NFDM, both S-CSN/JK and S-CSN/water formulations decreased relative 
bioaccessibility of EGC and EGCG following in vitro digestion to 9.1±2.4 and 4.7±0.6% 
(17.8±4.7 and 11.3±1.2 μmol/g) from beverages formulated with S-CSN/JK, and to 
6.8±1.0 and 4.9±0.1% (13.5±2.0 and 11.7±0.1 μmol/g) from beverages formulated with 
S-CSN/water. In addition, both EC and ECG bioaccessibility were significantly 
decreased (p<0.05) by formulation withS-CSN/JK buffer compared to formulation with 
NFDM from 68.7±2.9 and 10.9±1.1% (25.7±5.7 and 4.4±2.1 μmol/g) to 58.1±0.6 and 





Interestingly, although there was no significant dose dependent effect (p>0.05) on 
bioaccessibility of each flavan-3-ol for any treatment tested, it appears that relative and 
absolute bioaccessibility of EGC from green tea beverages formulated to 40% with S-
CSN (9.1±2.4% and 17.8±4.7 μg/g for S-CSN/JK buffer, 6.8±1.0% and 13.5±2.0 μg/g for 
S-CSN/water) are lower than formulations formulated to 10% of the test material 
(22.6±2.7% and 44.4±5.2 μg/g for S-CSN/JK buffer, 26.4±3.1% and 52.1±6.1 μg/g for S-
CSN/water) (Figure A.2). 
 
3.5 Green Tea Flavan-3-ol Bioaccessibility in Beverages Formulated with Individual 
Whey Proteins and Milk Minerals 
The impact of individual whey proteins on flavan-3-ol bioaccessibility was 
investigated. Both α-LA and β-LG were formulated in JK buffer at levels that represent 
those found in fat-free milk to better compare effects of each protein relative to JK buffer 
control, NFDM and S-CSN/JK formulations. 
Total flavan-3-ols level in α-LA in buffer DG (13.90±0.74 μmol/digestion reaction), 
β-LG in buffer DG (14.48±0.28 μmol/digestion reaction) and buffer control DG 
(16.86±0.66 μmol/digestion reaction) were not significantly different (p>0.05) than dd 
water control (8.64±0.50 μmol/digestion reaction) (Table 9). With regards to individual 
flavan-3-ols, absolute levels of EGC in DG of beverages formulated with α-LA and β-LG 
(7.12±0.47 and 8.44±0.25 μmol/digestion reaction, respectively) were not significantly 
different (p>0.05) compared to buffer without protein added (7.90±0.64 μmol/digestion 
reaction) (Figure 8, Table 10). In terms of bioaccessibility, whey proteins had no 





Table 10). Relative bioaccessibilities of EGC from α-LA and β-LG were 45.5±2.8 and 
54.7±0.3%, respectively, and absolute bioaccessibilities were 89.6±5.6 and 107.6±0.6 






Figure 8: Levels of (a) EGC, (b) EC, (c) EGCG, and (d) ECG in starting material and 
aqueous digesta of green tea beverages formulated with whey proteins or sodium 
caseinate in buffer and buffer control. Presence of different letters within raw material 






















































































































































































































































































Figure 7: Relative bioaccessibility (%) of flavan-3-ols from green tea beverages 
formulated with whey proteins or sodium caseinate in buffer and buffer controls. 




Beverages formulated with individual whey proteins had significantly decreased 
DG levels of EC, EGCG and ECG compared to JK control: their respective levels in α-
LA DG were 3.34±0.15, 2.89±0.54 and 0.55±0.8 μmol/digestion reaction; and in β-LG 
DG were 2.73±0.08, 2.81±0.09, and 0.50±0.02 μmol/digestion reaction (Figure 8, Table 
10). Bioaccessibilities of EGCG and ECG were significantly (p<0.05) decreased by α-LA 
compared to buffer control to 10.9±1.8 and 10.4±1.1% (26.2±3.5 and 4.2±2.2 μmol/g), 
respectively (Figure 9, Table 10). However, bioaccessibility of EC from α-LA 
formulation (79.7±2.0%, 29.8±3.9 μmol/g) was not significantly different (p>0.05) 



























































































































































































































































EC, EGCG, and ECG compared to buffer control to 62.8±2.9, 11.9±0.6, and 10.7±0.6%, 
respectively (23.5±5.6, 28.6±1.1, and 4.3±1.2 μmol/g, respectively).  
Flavan-3-ol relative bioaccessibility from whey protein formulated beverages were 
compared to NFDM formulations to determine extent to which they may be responsible 
for effects from a more complex NFDM system (Figure 9, Table 10). Compared to 
NFDM, α-LA significantly (p<0.05) decreased relative bioaccessibility of EGC to 
45.5±2.8% (89.6±5.6 μmol/g) and significantly increased (p<0.05) bioaccessibility EC to 
79.7±2.0% (29.8±3.9 μmol/g), but did not significantly (p>0.05) affect bioaccessibility of 
EGCG or ECG. No significant (p<0.05) differences in bioaccessibility of individual 
flavan-3-ols were found between β-LG and NFDM formulations.  
Bioaccessibility of flavan-3-ols from whey protein in JK buffer formulations was 
also compared to bioaccessibility of those from S-CSN in buffer formulations (Figure 9, 
Table 10). Whey protein formulations had significantly increased (p<0.05) 
bioaccessibilities of gallated flavan-3-ols compared to S-CSN in buffer formulations. In 
addition, α-LA and β-LG formulations had significantly increased EC and ECG 
bioaccesibility compared to S-CSN in buffer formulations.  
 
3.6 Protein Digestibility through Simulated GI Model 
SDS-PAGE analysis was utilized to characterize extent of protein digestion through 
the in vitro digestion model utilized for the bioaccessibility study (Figure 10). According 
to preliminary results, the most prominent bands for each raw material used in this 
investigation correspond to protein with the following molecular weights: <14.4 kDa for 





background enzymes correspond to protein with molecular weights ranging from 25 to 70 
kDa for pancreatin, and 66 kDa for pepsin (See Appendix Figure B.1). For all protein 
digestas, it appears that after 1 hour of gastric digestion bands resulting from separation 
of undigested digested protein are present, but at lower concentrations. Furthermore, it 
appears that protein had been digested to form lower molecular weight peptides. 
Specifically, it appears proteins present in S-CSN G0 (undigested) range from 14-35 kDa, 
with most of them between two large bands: one around 25 and one around 30 kDa. All 
proteins above 14 kDa disappeared after one hour of digestion (S-CSN G1), and thick, 
faint protein bands appeared below 14 kDa. β-LG G0 had one prominent protein band 
just above 14 kDa, which corresponds to β-LG monomer (molecular weight 18.4 kDa) in 
agreement with other studies (J. Mouécoucou et al. 2004; Mandalari et al. 2009; Otte et al. 
1997). This band is present in β-LG G1, but is less prominent. These results indicate 
some level of protein digestion during gastric phase consistent with exposure to pepsin.  
Changes in protein profile of α-LA, however, are harder to distinguish due to poor 
resolution of low molecular weight proteins by the type of gel used in this study.  
For all milk proteins, bands present following gastric digestion disappeared after just 
15 minutes of small intestinal digestion. This indicates that proteins and large 
polypeptides were rapidly digested to molecular weights less than 10 kDa from exposure 






Figure 10: Protein profile of (a) S-CSN, (b) β-LG, and (c) α-LA digests. The following 
are the lane designations for each gel: Lane 1 (and lane 9 in Figure 1.C): molecular 
weight markers; lanes 2 and 3: peptic digests (0 and 1 hour incubation, respectively); 
lanes 4-7: pancreatic digests (15, 30, 60, and 120 minutes incubation, respectively); lane 
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3.7 Characterization of Milk Protein-EGCG Binding by Fluorescence Spectroscopy 
Conditions of digestive environment and protein digestion may impact 
interactions between flavan-3-ols and protein/peptides. As sodium caseinate is the most 
abundant protein in milk, it was chosen as the model protein to investigate: (1) S-CSN-
EGCG binding interactions facilitated by digestive pH (gastric pH 3.0, duodenal pH 6.5) 
(2) extent of binding between EGCG and digestive enzymes and (3) combined effect of 
protein digestion, pH, and presence of enzymes in S-CSN digesta on fluorescence 
quenching of protein Trp residues by EGCG (Table 11, Figure 12).  
 
 
Figure 12: Percent Trp fluorescence quenched of protein solutions by EGCG. S-CSN 
solutions and EGCG (12μM) or Tris HCl were mixed 1:1 for analysis by fluorescence 
spectroscopy. Each line represents one of three different procedures used to determine: 
( ) extent of binding between EGCG and digestive enzymes, ( ) S-CSN-EGCG 
binding effects due to digestive pH (gastric pH 3.0, duodenal pH 6.5), and ( ) 
combined effect of protein digestion, pH, and presence of enzymes in S-CSN digesta on 
fluorescence quenching of protein Trp residues by EGCG.  The area of the graph before 
the first vertical dotted line corresponds with untreated protein, followed by protein 
































Table 11: Percent Trp fluorescence quenched by EGCG of protein solutions. Protein 
solutions and EGCG (12μM) or Tris HCl were mixed 1:1 for analysis by fluorescence 
spectroscopy. Each line is one of four different procedures used to determine: (1) extent 
of binding between EGCG and digestive enzymes (2) S-CSN-EGCG binding effects due 
to digestive pH (gastric pH 3.0, duodenal pH 6.5) and (3) combined effect of protein 
digestion, pH, and presence of enzymes in S-CSN digesta on fluorescence quenching of 
protein Trp residues by EGCG. Different letters between digests within a treatment 
denotes significant difference (p<0.05). 
 
Treatment Incubation Fluorescence Quenched (%) 
(1) Enzymes,  
pH 3 and 6.5 
G0 19.2 ± 1.1a,b 
G1 23.0  ± 1.4a 
D15 14.8 ± 1.6b,c 
D30 13.6 ± 0.4c 
D60 16.0 ± 0.8b,c 
D120 17.0 ± 0.6,c 
(2) S-CSN,  
no enzymes,  
pH 3 and 6.5 
G0 29.8 ± 1.6a 
G1 32.6 ± 0.5a,c 
D15 42.6 ± 3.9b 
D30 41.1 ± 1.4b 
D60 39.5 ± 1.7b,c 
D120 40.8 ± 1.5b,c 
(3) S-CSN, 
enzymes, 
pH 3 and 6.5 
G0 13.1 ± 2.4a 
G1 16.7 ± 0.5a 
D15 15.2 ± 1.6a 
D30 13.9 ± 0.9a 
D60 13.9 ± 1.4a 
D120 14.5 ± 2.2a 
 
 
%Fq of S-CSN incubated at gastric pH and 37°C for 0 or 1 hr (GpH0, GpH1) was 
29.8±1.6 and 32.6±0.5% (Table 11, Figure 12). %Fq of S-CSN incubated at duodenal pH 
and 37°C for 15 min to 2 hr (DpH15, DpH30, DpH60, DpH120) was higher in 





(p<0.05) %Fq compared to all S-CSN samples incubated at duodenal pH: %Fq was 
29.8±1.6% for GpH0 compared to 42.6±3.9, 41.1±1.4, 39.5±1.7, and 40.8±1.5% for S-
CSN DpH15, DpH30, DpH60, and DpH120. However, S-CSN GpH1 %Fq (32.6±0.5) 
was significantly lower (p<0.05) compared DpH15 and DpH30, but not DpH60 and 
DpH120. No significant differences (p<0.05) were found within gastric or duodenal 
samples. 
%Fq of enzymes incubated at gastric pH for 0 or 1 hr at 37°C (EG0, EG1) was 
19.2±1.1 and 23.0±1.4% (Table 11, Figure 12). %Fq of enzymes incubated at duodenal 
pH for 15 to 120 min at 37°C (ED15, ED30, ED60, ED120) was lower, ranging from 
13.6±0.4 to 17.0±0.6%. EG1 %Fq was significantly higher (p<0.05) compared to all 
enzyme samples incubated at duodenal pH: %Fq was 23.0±1.4% for EG1 compared to 
14.8±1.6, 13.6±0.4, 16.0±0.8, and 17.0±0.6% for ED15, ED30, ED60, and ED120. 
However, EG0 %Fq (19.2±1.1%) was significantly higher (p<0.05) compared to only 
ED30. No significant (p<0.05) differences were found within gastric or duodenal samples. 
%Fq of each digesta resulting from digestion of S-CSN by pepsin for 0 to 1 hour 
at 37°C and pH 3.0±0.1 (FG0, FG1) and by pancreatin for 15 to 120 minutes at 37°C and 
pH 6.5±0.1 (FD15, FD30, FD60, FD120) ranged from 13.1±2.4 to 16.7±0.5% (Table 11, 
Figure 12). There were no significant differences (p<0.05) in %Fq between samples. FG0, 
FG1, FD15, FD30, FD60, and FD120 %Fq were 13.1±2.4, 16.7±0.5, 15.2±1.6, 13.9±0.9, 
13.9±1.4, and 14.5±2.2%. 
%Fq from S-CSN samples incubated without enzyme (GpH0 to DpH120) were 
significantly higher (p<0.05) compared to all enzyme samples incubated without protein 





fluorometric analysis (FG0 to FD120) (See Appendix Table C.4). However, %Fq EG0 







CHAPTER 4. DISCUSSION 
Prior studies have investigated binding interactions between monomeric flavan-3-ols 
and proteins derived from foods and from the body (ie. digestive enzymes). With regards 
to milk proteins, evidence suggests that α- and β-CSN, α-LA, and β-LG all have capacity 
to interact with EGCG, as well as other flavan-3-ols, binding non-specifically with 
various affinities (Almajano et al. 2007; Hasni et al. 2011; Kanakis et al. 2011; von 
Staszewski et al. 2012; Bohin et al. 2012; Jöbstl et al. 2006; Tantoush et al. 2012; Prigent 
et al. 2009). Non-specific binding of milk proteins with flavan-3-ols occurs primarily 
through hydrophobic interactions (driven by London dispersion interactions) and 
hydrogen bonding interactions and, to a lesser extent, electrostatic interactions. 
Interactions tend to increase with polyphenol molecular weight, hydrophobicity, 
galloylation, hydroxyl groups, and decrease with methylation, methoxylation, 
glycosylation, and hydrogenation of the C2=C3 double bond (Soares et al. 2007; de 
Freitas et al. 2001; Baxter et al. 1997; Xiao et al. 2011; Xu & Chen 2011; Papadopoulou 
et al. 2005). Protein characteristics that promote interactions with polyphenols include 
presence of proline, histidine, arginine, phenylalanine and hydrophobic pockets and 
residues (Yan et al. 1995; Naurato et al. 1999; Charlton et al 2002; Baxter et al. 1997; 
Charlton et al. 2001; Soares et al. 2007; Papadopoulou et al. 2005). Types and strengths 





Table 2 (See Section 1.6.2). Implications of such interactions in food extend to the GI 
after consumption as non-specific binding may alter availability of flavan-3-ols for 
reactions and absorption.  While limiting accessibility for reactions, binding may serve to 
stabilize polyphenol with respect to potential oxidative degradation, and strong binding 
may serve to make these phenolics less available for absorption (bioaccessibility). 
Therefore understanding extent and implications of such interactions is needed in order to 
optimize stability but also availability of polyphenols for delivery of health benefits. 
The ability of protein to influence flavan-3-ol bioavailability remains controversial.  
While minimal impact on bioavailability of flavan-3-ols has been observed in clinical 
studies with black tea based systems (van het Hof et al. 1998; Kyle et al. 2007), in cocoa 
products, presence of milk protein appears to have a negative effect on monomeric 
flavan-3-ol bioavailability (Serafini et al. 2003; Neilson et al. 2009).   The influence of 
protein on tea flavan-3-ol bioactivity however, has been observed. Milk had no effect on 
plasma antioxidant activity following consumption of green or black tea by humans in 
vivo (Leenan et al. 2000), however milk decreased vasorelaxation effects of black tea in 
humans (Lorenz et al. 2007). While many studies attribute changes in bioactivity to 
reduced bioavailability, this effect is unclear.  Further, the impact of minerals derived 
from milk on flavan-3-ol stability and bioavailability has not been truly explored.  
Considering the important interplay between protein-minerals, minerals-flavan-3-ols and 
flavan-3-ols-protein, additional insight is needed.  The purpose of this study was 
therefore to determine effects of key milk proteins individually and in NFDM matrix as 





bioaccessibility of green tea flavan-3-ols.  As a secondary objective extent to which non-
specific binding of flavan-3-ols to milk protein during digestion was assessed by 
fluorometry.  
Relative (%) and absolute (μg/g) bioaccessibility was calculated for green tea 
beverages formulated with three different concentrations (10, 20, 40%) of each test 
material. There was no significant (p>0.05) concentration effect for any treatment tested 
(Figures A.1-A.4). Therefore, it is important to note that this discussion will be based 
primarily on bioaccessibility of flavan-3-ols from green tea powdered extract formulated 
into model beverages with 40% test material (protein or buffers). 
 
4.1 Impact of Milk Minerals on Flavan-3-ol Bioaccessibility 
Green tea powder was formulated with either JK buffer or dd water into model 
beverage systems and subjected to in vitro digestion to determine the impact of milk 
minerals on digestive stability of flavan-3-ols. Auto-oxidative degradation of flavan-3-ols 
during gastrointestinal digestion has been previously reported (Yoshino et al. 1999; Zhu 
et al. 2002; Green et al. 2007; Neilson et al. 2007; Ferruzzi et al. 2010). These reactions 
are facilitated by the elevated pH of the small intestine and rely on reactivity of the 
flavan-3-ol B-ring making EGC and EGCG more suceptable to oxidative loss by virtue of 
their galloyl structure relative to the catechol structure of EC and ECG (Neilson et al. 
2007).  Degradation of flavan-3-ols in model beverages formulated with dd water was 
consistent with those previously reported for tea (Green et al., 2007; Neilson et al., 2007; 
Record & Lane, 2001).  Interestingly, bioaccessibilities of all flavan-3-ols were 





formulation (p<0.05) relative to dd water (Figure 7, Table 10). This effect waslikely due 
to presence of divalent metal ions including calcium (Ca) and magnesium (Mg) at levels 
of 35.9 mg/100mL (9 mM) and 7.8 mg/100mL (3.3 mM), respectively, in the JK buffer 
system utilized in these studies. These minerals have been previously shown to interact 
with polyphenols in various foods altering both mineral stability and bioaccessibility 
(Vitali et al. 2008; Al-Numair 2009).  
In terms of potential polyphenol interactions, several studies have reported 
interactions between catechols, flavonoids and select metals (Namasivayam & Sumithra 
2004; Turkel et al. 2004). Polyphenols are well known as metal chelators (Hagerman et al. 
2003; Sugihara et al. 2001; Hider et al. 2001; Kumamoto et al. 2001).  Results from IR 
analysis (Yamada et al. 2007) suggest that calcium chelation occurs by either two 
hydroxyl groups within catechols, commonly present on the B-ring of flavan-3-ols, or by 
calcium bridging formations between multiple catechols. Flavonoids complexed in such a 
manner with metal were reported to be less susceptible to oxidation compared to 
uncomplexed flavanoids (Kostyuk et al. 2004). As previously stated, auto-oxidation is 
believed to be the primary degradative pathway for flavan-3-ols in the gut lumen due, in 
part, to the elevated pH of the intestinal compartment (Green et al. 2007; Nielson et al. 
2007).  In the case of the present study it is highly likely that milk minerals provide a 
measure of stabilization through their ability to reduce oxidative reactivity of individual 
tea flavan-3-ols, including highly susceptible EGC and EGCG. These control 
experiments were thus critical in our ability to distinguish effects in more complicated 
milk protein systems that also contain significant amounts of minerals that may compete 





4.2 Impact of NFDM on Flavan-3-ol Bioaccessibility 
In order to determine the impact of milk proteins on flavan-3-ol bioaccessibility 
we first formulated green tea beverages with reconstituted NFDM (10-40%) generating 
products similar to 10-40% single strength milk addition to tea.  These model beverages 
were compared to green tea beverages formulated with dd water to determine effects of 
the entire milk matrix on flavan-3-ol digestive stability and to evaluate the relationship 
with that reported by previous investigators (Green et al. 2007; van der Burg-Koorevaar 
et al. 2011; Xie et al. 2012). Tables 4 and 5 outline beverage type and polyphenol and 
milk protein content used for aforementioned in vivo and in vitro protein-polyphenol 
interaction studies. Beverages formulated with NFDM were found to have significantly 
higher (p<0.05) relative and absolute bioaccessibility of EGC and EGCG compared to 
those formulated with dd water, however, no significant impacton bioaccessibility of EC 
and ECG was observed (Figure 7, Table 10).  Green et al. (2007) previously reported that 
formulation of green tea beverages (49 mg/mL flavan-3-ols) with up to 50% milk 
improved bioaccessibility of EGC and EC, with no impact to bioaccessibility of EGCG, 
and decreasing bioaccessibility of ECG. However, addition of milk at 10 and 20% 
increased bioaccessibility of EGC and was reported to have no effect on bioaccessibility 
of remaining flavan-3-ols. In another study, formulation of milk to as low as 10% in 
boiled green tea (75 mg/mL flavan-3-ols) decreased bioaccessibility of gallated flavan-3-
ols, and formulation of milk up to 25% had no effect on bioaccessibility of EGC and EC. 
However, formulation of milk to 10% in ambient temperature green tea decreased 
bioaccessibility of EC, and an increase of milk in formulation to 25% decreased 





previously described, beverage preparation and temperature may be responsible for subtle 
differences in reported interactions and impacts of these protein-flavan-3-ol interactions 
(Xie et al. 2012). Further, inconsistencies in results between studies discussed here may 
be due to differences in experimental design including: type of digestion (three-stage vs. 
two-phase); level of digestive enzymes used;environmental conditions (pH of duodenal 
phase); and formulation (amount and type of tea or milk).  
Based on the general chemistry of proteins and flavan-3-ols present in GT-NFDM 
beverages, there are a few possible explanations for results obtained in our study. 
Gallated flavan-3-ol bioaccessibility was increased by addition of NFDM compared to 
controls formulated with dd water, however no effect was found with regards to non-
galloylated flavan-3-ols. This may be due to their greater extent of phenolic and hydroxyl 
groups available for hydrophobic stacking and hydrogen bonding, respectively, with 
intact protein and/or peptides by galloylated flavan-3-ols. Enhancement in 
bioaccessibility of select tea flavan-3-ols by addition of NFDM suggest that proteins 
present during digestion may be binding flavan-3-ols in the product and that these 
interactions likely continue through initial portions of the digestion process.  However, 
following extensive digestion of protein, flavan-3-ols are released into the gut lumen. 
Therefore interaction between specific milk proteins and green tea flavan-3-ols may 
provide some level of protection for individual flavan-3-ols from oxidative degradation in 
the upper small intestinal phase and increases availability for intact polyphenols to be 
subsequently absorbed in the upper small intestinal epithelia (bioaccessibility). Increased 
bioaccessibility may also translate to increased bioavailability as evidence exists to 





of milk to green tea (69.3 mg/mL flavan-3-ols) to 25% in the formulation increased 
flavan-3-ol transport across Caco-2 cell membranes compared to beverages formulated 
with milk to 10% (Xie et al. 2012), and addition of milk protein (2.45 g) to cocoa 
beverages containing 10 mg/mL cocoa polyhenols slightly accelerated flavan-3-ol 
absorption in humans (Keogh et al. 2007). 
Green tea beverages formulated with NFDM were also compared to those 
formulated with milk minerals to gain insight into the impact of milk protein relative to 
effects derived by interactions with just milk minerals (Figure 7, Table 10). Compared to 
beverages formulated with milk minerals, NFDM significantly increased (p<0.05) 
bioaccessibility of EGC, and decreased (p<0.05) bioaccessibilities of EC, EGCG, and 
ECG, suggesting that interactions between galloylated flavan-3-ols and milk proteins 
may be conserved during digestion, decreasing flavan-3-ol bioaccessibililty relative to 
interactions with milk minerals in test beverages. However, this could also suggest that 
milk mineral interactions may result in soluble complexes that are more stable during 
digestion than milk protein interactions to better preserve stability of flavan-3-ols.   
However, these results remain somewhat inconclusive as interactions between 
milk minerals and protein (as with NFDM) may alter availability for both minerals and 
proteins that would result in fewer milk mineral-flavan-3-ol interactions or flavan-3-ol-
protein interactions and by extension less flavan-3-ol stability through the GI tract. Also, 
mineral presence is well known to alter protein structure.  The impact of milk minerals on 
casein structure has been extensively reviewed (Swaisgood; Fennema; Payens et al. 1979; 
Rollema 1992; Shmidt 1980). Minerals, especially calcium, are required to impart 





content and casein net charge alter casein structure (Ouanezar et al. 2012; Moitzi et al. 
2011). In addition, studies show that minerals may modulate hydrophobic interactions 
between whey proteins (Phillips et al. 1991), reduce their charge (Schmidt et al. 1978), 
and aid in formation of whey protein gels (Schmidt et al. 1984). Thus, part of NFDM 
effect is due to mineral presence. It is therefore likely that observations concerning 
impact of NFDM proteins on flavan-3-ol bioaccessibility from green tea are more 
accurate when the treatment is compared to matching controls containing milk minerals 
than to those lacking milk minerals. Although significant differences in bioaccessibility 
were found between NFDM treatment and buffer control beverages, differences were 
modest (about 20, 15, 4, and 5% difference for EGC, EC, EGCG, and ECG, respectively) 
and thus may not have significant physiological consequences (Figure A.1).  Therefore, 
while these data provide evidence of interactions and modulation of flavan-3-ol 
bioaccessibility, it would generally agree with previous reports of the minimal impact of 
milk on polyphenol bioavailability from tea beverages (van het Hof et al.1998; Hollman 
et al. 2001; Kyle et al. 2007; Keough et al. 2007; Roura et al. 2007; Schramm et al. 
2003 ). 
 
4.3 Impact of Milk Minerals and Individual Milk Proteins on Bioaccessibility of 
Flavan-3-ols from Green Tea Beverages 
Differences in flavan-3-ol bioaccessibility from S-CSN/water compared to S-
CSN/JK beverages were investigated to better define the role of protein in presence and 
absence of milk minerals. There appeared to be no overall effect of milk mineral buffer 





outcompetition of flavan-3-ol-mineral interactions by strong interactions between S-CSN 
and flavan-3-ols. The impact of S-CSN/water on flavan-3-ol bioaccessibility was greater 
compared to milk minerals, supporting this notion (Figure 7).  
To determine the impact of individual milk proteins, matching digestions were 
completed with S-CSN, α-LA, and β-LG solubilized in either dd water or buffer at 
concentrations reflecting those found in milk replacing NFDM in the formulations. 
Results from these studies suggest that formulation of JK in place of dd water in green tea 
beverages altered in vitro bioaccessibility of flavan-3-ols. Furthermore, JK contains salts 
found in milk serum, and thus addition of proteins solubilized in buffer to green tea 
beverages should allow for a more accurate assessment of how green tea flavan-3-ols and 
proteins may interact in a milk system. Therefore, two key whey protein in milk (α-LA, 
and β-LG) were solubilized in JK (1.0 and 3.5 mg/mL, respectively), formulated in green 
tea beverages between 0.1-0.4 and 0.35-1.4 mg/mL, respectively,and digested in vitro. 
Bioaccessibilities of flavan-3-ols from each type of beverage formulated with an 
individual milk protein (S-CSN, α-LA, or β-LG) in JK, matching controls, and beverages 
formulated with NFDM were then compared. 
Addition of each individual protein into the final formulation affected 
bioaccessibility of tea flavan-3-ols. S-CSN in JK significantly decreased bioaccessibility 
of all flavan-3-ols compared to JK control (Figure 9, Table 10). The micellar structure of 
casein is disrupted when converted to sodium caseinate and sub-micelle like structures 
can be formed containing α-s1, α-s2, β, and κ-caseins at 4:1:4:1.3, with the bulk of non-
polar regions residing in an inner core and hydrophilic regions on the outer layer (Farrell 





casein constituents to flavan-3-ols has been explored. Caseinomacropeptide was reported 
to form complexes with green tea flavan-3-ols irrespective of pH (von Staszewski 2012). 
Additionally, results following ultrafiltration of milk proteins with flavan-3-ols suggest β-
casein (β-CSN) has high binding affinity and high binding capacity for EGCG compared 
to β-LG. β-CSN may have a high affinity for EGCG due to presence of aromatic amino 
acids and histidines in its structure (Bohin et al. 2012). Results from single molecule 
force microscopy implied that β-CSN wraps around EGCG, becoming more stiff and 
compact. The deformation of β-CSN around EGCG was entropic, indicating hydrophobic 
interactions were the primary force of interaction. Additionally, no enthalpy effects were 
observed, indicating hydrogen bonding is relatively weak in comparison to hydrophobic 
interactions (Jöbstl et al. 2006). Another study confirmed through circular dichromism 
and fluorescence spectroscopy that α- and β-CSNs interact with tea flavan-3-ols through 
hydrophobic interactions between flavan-3-ol phenolic rings and hydrophobic pockets of 
casein, altering protein structure resulting in protein unfolding. The authors also 
suggested that intramolecular hydrogen bonds may tighten the casein structure around the 
flavan-3-ol (Hasni et al. 2011).  
Although the ability of various types of caseins to bind flavan-3-ols has been 
demonstrated, it is not clear how sodium caseinate interacts with flavan-3-ols. 
Furthermore, sodium caseinate is very susceptible to pepsin hydrolysis (Guo et al. 1995).  
It was therefore suprising that these interactions both survived and had effects on ultimate 
bioaccessibility of flavan-3-ols. To better explore this effect, digestion experiments were 
designed to test interactions between intact EGCG and milk protein hydrolysates and will 





Interestingly, flavan-3-ol bioaccessibility was lower in green tea beverages 
formulated with S-CSN compared to NFDM formulations. As mentioned above, the 
structure of casein is significantly disrupted during production of sodium caseinate. On 
the other hand, casein micelles are partly restored after reconstitution of NFDM (Sharma 
et al. 1996). Therefore, due to differences in structures between sodium caseinate and 
casein present in reconstituted NFDM, their potential for interactions with flavan-3-ols 
may differ. The observed differences in flavan-3-ol bioaccessibility suggest that 
interactions between sodium caseinate and GT flavan-3-ols may be greater than when 
casein is present in a more natural state as from reconstituted NFDM or from fresh milk.  
Therefore, formulation of products should begin to consider not just protein source but 
form of the protein used if delivery of biologically relevant flavan-3-ols is a key aspect of 
the product. 
Interestingly, this notion was previously observed when comparing the impact of 
milk and sodium caseinate-based nondairy creamer on bioavailability of phenolics 
(Renouf et al. 2010). Compared to regular instant coffee, maximum plasma concentration 
(Cmax) of chlorogenic acid and metabolites were significantly lower and time needed to 
reach Cmax (Tmax) was significantly longer in coffee beverages formulated with nondairy 
creamer.  However, addition of milk to coffee beverages had no effect on phenolic Cmax 
or Tmax, suggesting potential for fewer or weaker protein-phenol interactions. The 
primary difference between milk and nondairy creamer is the structure of the casein 
complex present in the system: milk contains colloidal casein, whereas nondairy creamer 
typically contains sodium and/or calcium caseinate (Gardiner 1977; Buddemeyer 1980). 





extent than casein present in natural micelles, ultimately delaying phenolic intestinal 
absorption and altering parameters of bioavailability. Although the structure of sodium 
caseinate is not clear, it can be postulated that more hydrophobic residues are exposed on 
sodium caseinate compared to casein micelles, strengthening its interaction with flavan-
3-ols. As a result, release of flavan-3-ols from complexes with sodium caseinate may 
occur later than from complexes with casein micelles, therefore increasing time to flavan-
3-ol uptake by small intestinal epithelial cells. 
With regards to whey proteins, α-LA (assessed at 0.1-0.4 mg/mL) significantly 
decreased (p<0.05) both relative and absolute bioaccessibility of both EGCG and ECG 
compared to buffer control, but had no significant (p>0.05) impact on EGC or EC (Figure 
9, Table 10). α-LA has a net negative charge at the pH of milk (pH 6.3-6.6) and folds 
intramolecularly burying most hydrophobic residues (Swaisgood 1996). This structure 
would conceivably make hydrophobic sites less available for interaction with phenolic 
ring structures. Therefore with regards to binding interactions, hydrogen binding should 
predominate between α-LA and gallated flavan-3-ols in an undigested state. However, α-
LA is rapidly degraded by pepsin (Fu et al. 2002). Thus, digested α-LA may expose 
hydrophobic residues that may in turn associate with gallated flavan-3-ols through GI 
digestion and result in reduced bioaccessibility.  
Recent studies have explored specific interactions between α-LA and flavan-3-ols 
using SDS-PAGE and particle size analysis (von Staszewski et al. 2011; Tantoush et al. 
2012). At pH 4.5, (α-LA’s isoelectric point) incubation of whey protein concentrate 
solutions (8% w/v in dd water) with green tea flavan-3-ols at 0.25% (w/v) for 24 hours 





hand, incubation of the same solution at pH 6.0 generated smaller soluble complexes 
requiring increased levels of polyphenol (1% w/v) for precipitation (von Staszewski et al. 
2011). Another study showed that α-LA (1.0 mg/mL) remained in soluble portion of 
solutions containing green tea flavan-3-ols (0.2 mg gallic acid equivalents per mL) after 5 
minutes of incubation in acetate buffer (pH 4.5). However, α-LA was insoluble in 
presence of oxidized green tea flavan-3-ols, suggesting rapid formation of insoluble 
complexes between α-LA and oxidized green tea flavan-3-ols (Tantoush et al. 2012). 
These results suggest that incubation conditions (time, pH) as well as oxidation state of 
flavan-3-ols affect extent of flavan-3-ol-α-LA interactions. In the present study α-LA was 
primarily exposed to pHs above and below its isoelectric point likely resulting in soluble 
complexes between α-LA and flavan-3-ols, specifically favorable for gallated flavan-3-
ols (EGC, EGCG and ECG), explaining, in part, the effect of decreasing their 
bioaccessibility.  
Non-gallated flavan-3-ol (EC) relative and absolute bioaccessibility was not 
significantly impacted by presence of α-LA in comparison to JK buffer control. 
Previously, Prigent et al. (2009) reported low affinity of α-LA for EC using isothermal 
titration calorimetry. It appears that gallation is important in binding between α-LA and 
flavan-3-ols as it has been reported for other proteins including salivary proteins, casein 
and albumins (de Freitas et al. 2001; Baxter et al. 1997; Xiao et al. 2011; Xu & Chen 
2011; Soares et al. 2007). Over 10% of α-LA amino acid residues are aromatic 
(Swaisgood 1996) making it plausible that hydrophobic stacking between galloyl groups 
and aromatic amino acids may be central in α-LA-flavan-3-ol interactions as it is for 





individual flavan-3-ol bioaccessibility were observed between α-LA treatment and buffer 
control beverages, it should be noted that these differences were less than 10% (Figure 
A.2).  Therefore, it is not expected that presence of α−LA would have significant impact 
on bioavailability of flavan-3-ols from tea through binding interactions.  The extent to 
which formulation would drive oxidation and thus loss of absolute bioaccessibility should 
be considered, however. 
β-LG (0.35-1.4 mg/mL) decreased relative and absolute bioaccessibility of EC, 
EGCG, and ECG compared to JK control (Figure 9, Table 10).  As with other protein 
interactions, this would be consistent with formation and preservation of β-LG-flavan-3-
ol associations during digestion. A recent study showed that β-LG complexed with green 
tea flavan-3-ols, irrespective of pH (von Staszewski et al. 2012). Similar to α-LA, β-LG 
(8% w/v) and polyphenols (0.25% w/v) interact at pH 4.5 forming large aggregates 
resulting in precipitation of β-LG from whey protein concentrate. Smaller particles form 
at pH 6.0, precipitating with addition of higher levels polyphenols (1% w/v) (von 
Staszewski et al. 2011). Molecular modeling indicated EGCG-β-LG interactions occur 
through H-bonding networks and hydrophobic interactions between flavan-3-ol phenolic 
rings and hydrophobic pockets in β-LG (Kanakis et al. 2011). Similar modeling methods 
suggest ECG-β-LG interactions occur through hydrogen bonding and van der Waals 
interactions (Wu et al. 2011). Furthermore, structural analysis shows that more EGCG 
binds to β-LG compared to other green tea flavan-3-ols, and ECG and EGC have the 
lowest and highest binding constants, respectively (Kanakis et al. 2011). These 
observations suggest that galloylated flavan-3-ols bind more readily to intact β-LG 





the surface, suggest that binding in the product would be maintained through digestion 
and impact availability for absorption.   Although significant, differences in individual 
flavan-3-ol bioaccessibility found between β-LG treatment and buffer control beverages, 
were moderate (about 20, 5, 5, and 6% difference for EGC, EC, EGCG, and ECG, 
respectively) (Figure A.1).  Therefore, as with other whey protein constituents, it is not 
expected that these interactions would have significant impact on bioavailability of 
flavan-3-ols from tea through binding interactions in the gut, but rather may drive some 
changes in bioavailability through stabilization or destabilization of tea flavan-3-ols 
through beverage formulation. 
 
4.4 Protein Digestibility through Simulated GI Model 
In order to confirm the extent of protein degradation by gastric and duodenal 
digestion, we digested milk proteins to various extents and separated contents of resulting 
digesta using SDS-PAGE analysis. S-CSN is susceptible to pepsin digestion (Guo et al. 
1995) and α-LA is susceptible to pepsin and pancreatin digestion (Fu et al. 2002; 
Tantoush et al. 2012) while β-LG is somewhat resistant to pepsin and trypsin digestion 
(Guo et al. 1995; Tantoush et al. 2011). However, digestive conditions in the present 
studies, including pH, combination of enzymes, and time are different than those used in 
these previously published studies. Therefore, SDS-PAGE analysis was used to assess the 
extent to which S-CSN, β-LG, and α-LA were digested in the in vitro digestion procedure 
utilized for flavan-3-ol bioaccessibility studies. 
After 1 hour of gastric digestion (G1) of S-CSN, bands resulting from separation of 





10). Less dramatic effects were observed for β-LG and α-LA digests. β-LG G1 
maintained similar protein profile compared to G0, however the level of the prominent 
protein decreased. This partial resistance to pepsin digestion was previously observed by 
another group (Guo et al. 1995; Tantoush et al. 2012). α-LA is a smaller protein with 
molecular weight barely above the limit of separation for the specific gels used for 
analysis. Therefore, there is very low resolution for the gastric phases, resulting in 
formation of a dark band at the bottom of the gel for undigested α-LA and α-LA G1, 
making it difficult to see any changes due to gastric digestion. However previous studies 
suggest that rapid degradation of α-LA occurs in presence of pepsin (Fu et al. 2002; 
Tantoush et al. 2012). For all protein digests, after 15 minutes of small intestinal 
digestion (D15), protein bands present in G0 and G1 digesta disappeared, indicating that 
peptides were broken down to <10 kDa rapidly from exposure to pancreatin during small 
intestinal digestion (Figure 10). Based on previous studies, extensive pancreatic digestion 
was expected for α-LA, but not β-LG (Fu et al. 2002; Tantoush et al. 2011, 2012).  β-LG 
may have been resistant to trypsin digestion (Tantoush et al. 2011) due to the very low 
trypsin:protein ratio (1:100). However, pancreatin contains other proteolytic enzymes and 
more accurately reflects the complexity of digestion in the human GI tract.  Therefore 
digestion would be expected in our current model.  Also, concentrations of proteases used 
in our studies were very high: 0.8 and 1.2mg/mL pepsin and pancreatin, respectively, in 
final digesta. This is about 3x the concentration used in previous studies (Garrett et al. 
2000).  
Milk proteins appear to be partially degraded during gastric digestion and are rapidly 





10).  This information may help to explain the increased binding of flavan-3-ols to 
proteins digested gastrically, and rapid decrease in binding of flavan-3-ols to proteins 
digested duodenally.  
The protein profile of digesta resulting from digestion of solely milk proteins may be 
very different if digested in presence of flavan-3-ols. Studies have shown that flavan-3-
ols bind digestive enzymes, decreasing extent of protein degradation (He et al. 2006; 
Nakai et al. 2005; Unno et al. 2009). For example, green and oolong tea polyphenols 
decreased activity of digestive enzymes (He et al. 2006; Nakai et al. 2005; Naz et al. 
2011). Therefore tea may alter protein digestibility and thus protein/peptide-flavan-3-ol 
interactions during digestion. 
 
4.5 Characterization of Milk Protein-EGCG Binding through Digestion 
Considering the apparent limited impact of milk proteins on digestive 
stability/release (bioaccessibility) of flavan-3-ols in our model system, the extent to 
which binding interactions may be destabilized through digestion was explored.  Prior 
studies have investigated binding of intact flavan-3-ols to milk proteins. Evidence shows 
that α- and β-CSN, α-LA, and β-LG all interact with flavan-3-ols with various binding 
affinities (Almajano et al. 2007; Hasni et al. 2011; Kanakis et al. 2011; von Staszewski et 
al. 2012; Bohin et al. 2012; Jöbstl et al. 2006; Tantoush et al. 2012; Prigent et al. 2009). 
External quencher accessibility has been previously used as method to assess binding 
interactions.  This method tracks changes in fluorescence tryptophan (Trp) in intact 





(Kumosinski et al. 1993). Fluorescence spectroscopy was therefore utilized to estimate 
flavan-3-ol binding through changes in protein Trp fluorescence.  
S-CSN was chosen as the model to demonstrate changes in polyphenol-protein 
binding throughout digestion because it is the most abundant protein in milk. EGCG was 
chosen as the model flavan-3-ol because it is the most abundant polyphenol in green tea 
and has high propensity for binding due to its abundance of galloyl and hydroxyl groups 
available for hydrophobic interactions and hydrogen bonding. Fluorescence of protein in 
presence of EGCG relative to its fluorescence without EGCG, %Fq, was calculated to 
determine extent of quenching and by extension “binding” between intact protein or 
peptides in digesta with EGCG. In the current study we investigated effect of gastric and 
duodenal pH (pH 3.0 and 6.5, respectively) on flavan-3-ol binding to S-CSN and 
contribution of Trp fluorescence quenched from background digestive enzymes (pepsin 
and pancreatin). Finally, all conditions were combined (S-CSN digestion, pH, and 
enzymes) to determine impact of the full system and compare to impact of each variable 
(Figure 12). 
Protein net charge and conformation change with pH thus altering location of 
amino acid residues on their structure possibly affecting extent of protein-flavan-3-ol 
binding. According to results, EGCG quenches significantly more (p<0.05) intact S-CSN 
fluorescence at pH 6.5 compared to pH 3.  Also quenching was significantly higher 
(p<0.05) with intact enzyme fluorescence at pH 3.0 compared to 6.5 (Figure 12). This 
may be due to repulsion between protein and EGCG near the protein’s isoelectric point or 
due to unfavorable charged distribution or conformation of protein for London dipole 





effect of protein digestion on milk protein-EGCG binding, it appears that protein 
hydrolysis and conformation both are major factors contributing to binding interactions 
with flavan-3-ols. 
Another factor that may impact flavan-3-ol milk protein interactions during 
digestion is presence of digestive enzymes. Studies have shown that flavan-3-ols interact 
with digestive enzymes (He et al. 2006; Nakai et al. 2005; Tagliazucchi et al. 2005; Naz 
et al. 2011). Flavan-3-ol-enzyme interactions may decrease available flavan-3-ols for 
interaction with milk protein. Therefore, we assessed fluorescence quenching of Trp 
residues from an enzyme cocktail containing pepsin and pancreatin at pH 3.0 and 6.5. 
Results indicated that EGCG quenches enzyme Trp fluorescence at both pHs evaluated 
(Figure 12). Thus, Trp fluorescence quenching observed in our system may be 
attributable to binding of EGCG with both digestive enzymes and test protein. Unlike S-
CSN, however, it appears that enzymes interacted with EGCG to a significantly (p<0.05) 
greater extent at pH 3.0 compared to pH 6.5.  Therefore, binding in the duodenal phase 
were most likely a result of residual interactions with peptides generated from digestion 
of milk proteins. 
An additional factor that may also impact flavan-3-ol binding to milk protein is 
protein digestion. Intact protein is stabilized by hydrogen bonds and hydrophobic and van 
der Waals interactions, with hydrophobic areas buried in the center of the molecule. 
During gastric digestion, proteins are partially denatured by low pH and pepsin digestion. 
Pepsin is an endopeptidase that hydrolyzes proteins into large peptides. It cleaves peptide 
bonds preferentially at carboxyl groups of tyrosine, phenylalanine, or tryptophan residues, 





chymotrypsin are serine endopeptidases in pancreatin that are active during small 
intestinal digestion. Trypsin preferentially cleaves peptide bonds with positively charged 
residues, such as arginine or lysine, and proline inhibits cleavage by trypsin. 
Chymotrypsin acts on bonds with large hydrophobic amino acid residues, such as 
tryptophan, phenylalanine, tyrosine, methionine, or leucine, in addition to trypsin and 
chymotrypsin. Pancreatin also contains a general protease, which cleaves peptide bonds 
non-specifically (Moughan & Stevens 2013). As peptide bonds within protein are cleaved, 
the structure unfolds uncovering buried polypeptide chains in a process termed 
demasking (Adler-Nissen 1986). Consequently, amount of ionizable groups is increased, 
and additional hydrophobic pockets may be exposed (Panyam & Kilara 1996; Vorob’ev, 
2013) and likely made available for additional interactions with flavan-3-ols.  
Furthermore, secondary and tertiary structure of the protein molecule is disrupted, and 
surface topology and molecular flexibility are altered.  
Studies have investigated the impact of milk protein hydrolysis by digestive 
enzymes on protein structure. With regards to casein, tryptic hydrolysis resulted in 
protein with lower molecular flexibility and higher α-helix and β-sheet (Wang et al. 
2013). Furthermore, hydrophobic residues were increased and ionic residues were 
decreased by both pepsin and pancreatic hydrolysis, resulting in attraction between 
protein molecules (Su et al. 2008). Potential structural changes to these proteins induced 
by digestion may therefore alter their ability to interact with flavan-3-ols.  Specifically, 
hydrophobic interactions, hydrogen binding, and van der Waals interactions (specifically 
London forces) may be altered favoring additional binding. In general, it appears that 





interactions with flavan-3-ols (Figure 12). However, after duodenal digestion 
protein/peptide degradation may be so extensive that potential for strong interactions with 
flavan-3-ols is decreased.  Therefore, while interaction during gastric digestion may be 
strong, interactions decrease as protein digestion continues to generate small peptides and 
amino acids during duodenal digestion. Subsequent to binding of protein to flavan-3-ol 
before or during gastric phase, the time the interaction survives without release will 
determine influence on flavan-3-ol bioaccessiblity: Release early in the duodenal phase 
decreases protection and potential for flavan-3-ol interaction with digested protein; 
release toward end of duodenal phase may increase bioaccessibility; and failure to release 
may decrease bioaccessiblity. Consequently, bioavailability may be altered modestly. 
Alternatively, interactions may delay uptake from small intestinal epithelium, increasing 
Tmax of flavan-3-ols in plasma, an effect observed for plasma kinetics of chlorogenic acid 
from coffee by addition of milk in the formulation (Reneuf et al. 2012). 
In this study, S-CSN was digested enzymatically and gastric and duodenal 
samples were pH adjusted to pH 3.0 or 6.5, respectively, before fluorometric analysis to 
determine the impact of complete digesta environment on Trp fluorescence quenching by 
EGCG. Results suggest that %Fq of S-CSN and digestive enzymes are not additive: Trp 
fluorescence quenched by the whole system was significantly lower (p<0.05) at every 
extent of S-CSN digestion compared to S-CSN incubated under the same conditions 
without enzyme (Figure 12) at 0 and 1 hour of S-CSN gastric digestion compared to 
enzyme incubated under the same conditions without S-CSN (Table C.4). Therefore, 
binding between EGCG with S-CSN and digestive enzymes appears to be non-





residues besides Trp, and may even bind these residues with greater affinity.  In addition, 
there were no significant (p<0.05) differences between %Fq of each phase of S-CSN 
digestion. Therefore, variations in fluorescence quenching of S-CSN and enzyme Trp 
residues observed due to pH and extent of S-CSN digestion may mitigate differences in 
binding of EGCG to protein/peptides throughout digestion.  Although binding is 
occurring between EGCG and proteins in each digesta, it is hard to distinguish to what 
extent the impact is due to S-CSN or digestive enzymes. By comparing fluorescence data 
with SDS-PAGE data, it can be hypothesized that during the gastric phase of digestion, 
S-CSN and its digestion products may bind EGCG appreciatively, however rapid 
digestion of S-CSN during the duodenal phase may mitigate binding between S-CSN 
digestion products. Therefore, binding that occurs during duodenal digestion may be 






CHAPTER 5. CONCLUSIONS AND FUTURE WORK 
5.1 Overall Conclusions 
In the present study, bioaccessibility of individual tea flavan-3-ols appeared to be 
affected by both presence and type of milk protein. Inclusion of S-CSN significantly 
decreased (p<0.05) relative and absolute bioaccessibility of all flavan-3-ols, β-LG 
significantly decreased (p<0.05) relative and absolute bioaccessibility of all flavan-3-ols 
except EGC, and α-LA significantly decreased (p<0.05) relative and absolute 
bioaccessibility of only gallated flavan-3-ols compared to buffer controls (Figure 9, Table 
10). We attribute these digestive losses to protein-flavan-3-ol interactions that balance 
both availability of flavan-3-ols for oxidative reactions in the gut environment and 
solubility of flavan-3-ol-protein complexes. That being said, the impact α-LA and β-LG 
had on flavan-3-ol bioaccessibility was moderate, while S-CSN had a greater impact. 
This is consistent with the body of literature on binding interactions between individual 
proteins and flavan-3-ols in model systems (Hasni et al. 2011; Kanakis et al. 2011; Bohin 
et al. 2012; Arts et al. 2002; Lorenz et al. 2007; Shpigelman et al. 2012). 
Perhaps most interesting, it appears that milk minerals may have more of an effect 
on flavan-3-ol bioaccessibility than milk proteins themselves. Beverages formulated with 
JK buffer containing milk minerals significantly increased (p<0.05) bioaccessiblity of all 





of protein, milk minerals appear to lose their ability to affect flavan-3-ol bioaccessibility, 
possibly due to loss of mineral-flavan-3-ol interactions to competition with mineral-
protein interactions (Figure 9, Table 10).   
Formation of flavan-3-ol-protein complexes appeared to be dependent on structure 
of both flavan-3-ol and protein. According to structural analysis executed in previous 
studies (Hasni et al. 2011; Kanakis et al. 2011; Jöbstl et al. 2006; Prigent et al. 2009; Wu 
et al. 2011) typical interactions involved in complex formation include hydrophobic 
interactions between phenolic rings of flavan-3-ols with aromatic amino acids and 
hydrophobic pockets of protein and, to a lesser extent, hydrogen bonding and van der 
Waals interactions, for example between hydroxyl groups of flavan-3-ols with protein. 
These interactions may protect flavan-3-ols from oxidative degradation, or render them 
insoluble in the gut. Protein that appears to have little or no affect on the bioaccessibility 
of a polyphenol either does not bind well to the particular polyphenol, or their interaction 
may be broken by proteases during gastric digestion.  
SDS-PAGE results from digestion of milk proteins imply that proteins are degraded 
by pepsin at concentrations used in this study: high molecular weight and low molecular 
weight proteins are decreased and increased, respectively, after 1 hour of digestion by 
pepsin (Figure 10).  
The impact of pH on intact S-CSN-EGCG and of S-CSN degradation by pepsin and 
pancreatin digestion on (poly)peptide-flavan-3-ol interactions was investigated to obtain 
a more detailed picture of these interactions during digestion (Figure 12). According to 
results, it appears that pH has the greatest impact on S-CSN-EGCG interactions (Figure 





compared to pH 3.0. Pepsin and pancreatin also complexed with EGCG, however binding 
occurred to a significantly greater (p<0.05) extent at pH 3.0 compared to pH 6.5. The 
change in propensity of protein to bind EGCG with pH is most likely due to changes in 
structure, amino acid distribution, and net charge of protein. 
Although changes in protein-EGCG interactions occurred due to change in pH, 
binding between EGCG and protein resulting from digestion of S-CSN to various extents 
were not significantly different (p>0.05) from each other (Figure 12, Table C.4). This 
indicates that combination of individual effects mitigates an overall change in protein-
EGCG binding between different stages of digestion. Furthermore, although 
protein/peptide-EGCG binding occurred, it is unclear to what extent these effects are due 
to EGCG binding to digestive enzymes. 
Taken together, in vitro digestion, fluorometry, and SDS-PAGE results suggest that 
milk protein-flavan-3-ol interactions are (1) dependent upon structure of both protein and 
polyphenol and (2) altered by gastrointestinal digestion. Therefore, interactions between 
flavan-3-ols and individual milk proteins may alter available flavan-3-ol levels following 
gastric digestion and delay absorption in the small intestine. Complexes appear to form 
during the gastric phase, decreasing bioaccessibility of flavan-3-ols and possibly 
protecting them from degradation by oxidative conditions. Subsequent degradation of 
protein during duodenal digestion may break these interactions, increasing 
bioaccessibility of intact flavan-3-ols, thus increasing levels available for absorption in 
the small intestine. These interactions would be more prominent as the S-CSN content 
increases. This would explain differences previously observed between bioavailability of 





al. 2010).   In addition to information obtained by in vitro digestion regarding protein-
polyphenol interactions, it appears that milk minerals interactions merit further 
investigation as these interaction may influence flavan-3-ol stability during digestion, 
thereby increasing flavan-3-ol bioaccessibility. 
 
5.2 Future Work 
While results from experiments outlined in this thesis suggest that protein-flavan-3-
ol complexes may be present in the gut following consumption of green tea with milk 
decreasing bioaccessibility of flavan-3-ols, the impact of these complexes with regards to 
bioavailability needs to be elucidated. In vitro data obtained from a Caco-2 cell culture 
model may clarify to what extent uptake, absorption, and metabolism of flavan-3-ols 
from small intestinal epithelial cells is affected by interactions between digested proteins 
with flavan-3-ols. In addition, colonic fermentation may be utilized to determine extent to 
which protein-flavan-3-ol interactions may inhibit catabolism of flavan-3-ols by colonic 
microflora to phenolic acids that may subsequently be absorbed into the blood stream 
more efficiently than the flavan-3-ols themselves. 
The protein profile of digesta resulting from digestion of solely milk proteins may 
be very different if digested in presence of flavan-3-ols. Studies have shown that flavan-
3-ols bind digestive enzymes, decreasing extent of protein degradation (He et al. 2006; 
Nakai et al. 2005; Unno et al. 2009). For example, intact and oxidized flavan-3-ols 
increased and decreased pepsin activity, respectively (Tantoush et al. 2012). Therefore, 
milk proteins should be digested in presence of flavan-3-ols, and the protein profile of the 





without flavan-3-ols to determine the extent to which flavan-3-ols alter digestion of 
proteins. Similarly, milk protein-flavan-3-ol digesta fluorescence can be compared to 
fluorescence of milk protein digesta mixed with flavan-3-ol digesta to compare binding 
of digested flavan-3-ols with milk protein digested with and without presence of flavan-
3-ols. 
Bioactive milk peptides are released from milk proteins by digestive enzymes. 
Some are resistant to further digestion (Reynolds et al. 1994), while others are broken 
down further, sometimes to more active peptides (del Mar Contreras et al. 2013; Quirós 
et al. 2009; Tavares et al. 2011). The impact of green tea flavan-3-ols on digestive release 
and/or stability of bioactive peptides may be of interest. This could be achieved by either 
1) amino acid sequencing to measure presence of established bioactive peptides, or 2) 
measuring an indicator of disease prevention (angiotensin converting enzyme inhibition, 
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Appendix A: Affect of Protein Concentration on Bioaccessibility of Green Tea Flavan-3-
ols in vivo. 
 
 Test solutions containing milk proteins were formulated to mimic concentrations 
naturally occurring in milk (NFDM; α-LA, β-LG and S-CSN in buffer; S-CSN in water) 
and formulated into green tea beverages at 10, 20, and 40%. There was no significant 
concentration effect (p<0.05) at the three concentrations tested. Therefore we discussed 
only beverages formulated to 40% with protein solution.   
Although there was no significant difference (p>0.05) in flavan-3-ol 
bioaccessibility from green tea beverages formulated with 10, 20, and 40% of test 
material (p<0.05) (Figures A.1, A.2, A.3, A.4), it appears that relative and absolute 
bioaccessibility of EGC from green tea beverages with formulated with 40% NFDM 
formulations (71.89±1.36% and 141.57±2.68 μg/g) are higher than formulations 
containing 10% of the test material (57.50±1.37% and 113.22±2.70 μg/g) (Figures A.1. 
and A.3) In addition, it appears that relative and absolute bioaccessibility of EGC from 
green tea beverages formulated to 40% with S-CSN (9.05±2.37% and 17.82±4.68 μg/g 
for S-CSN in buffer, 6.84±1.01% and 13.48±1.98μg/g for S-CSN in water) are lower than 
formulations formulated to 10% of the test material (22.55±2.65% and 44.40±5.22 μg/g 
for S-CSN in buffer, 26.44±3.08% and 52.06±6.06 μg/g for S-CSN in water) (Figures 







Figure A. 5: Relative bioaccessibility (%) of EGC, EC, EGCG, and ECG from green tea 


































































































































































Figure A. 6: Relative bioaccessibility (%) of EGC, EC, EGCG, and ECG from green tea 
beverages formulated with (a) α-lactalbumin, (b) β-lactoglobulin, and (c) sodium 
























































































































































































































Figure A. 7: Absolute bioaccessibility (μg/g) of EGC, EC, EGCG, and ECG from green 
































































































































































Figure A. 8: Absolute bioaccessibility (μg/g) of EGC, EC, EGCG, and ECG from green 
tea beverages formulated with (a) α-lactalbumin, (b) β-lactoglobulin, and (c) sodium 

















































































































































































































Appendix B: Protein Profiles of Raw Materials used for Digestions Preceding SDS-
PAGE and Fluorometric Analysis 
 
Figure B.2: Protein profiles of milk proteins and digestive enzymes used for digestions 















Appendix C: Fluorescence Quenching of Trp Residues by EGCG 
 
The data shown in appendix B is select preliminary data (Table C.1 and C.2) and data 
included in section 3.7 (Table C.3 and C.4), presented in table format. Method 
development was initiated following a method by Kanakis et al. 2011. The fluorescence 
spectra were obtained using λexc=280 nm and λemm from 290-500 nm and the intensity at 
350 nm (tryptophan (Trp)) was recorded. 
 
Preliminary tests showed that EGCG mixed 1:1 with Tris-HCl (buffer) fluoresced less 
than just Tris-HCl (Table C.1). In addition, it appeared EGCG quenched digestive 
enzyme fluorescence. Due to its low impact on fluorescence and ability to quench some 
enzyme fluorescence, EGCG flurescence was not corrected for in calculations for percent 
quenching of Trp residues by EGCG. 
 
Table C. 3: Fluorescence Intensity of EGCG and Digestive Enzyme Cocktail 
 
Fluorometric experiments were carried out on a Perkin-Elmer LS55 Spectrometer 
(Woodbridge, ON, Canada). Method development was initiated following a method by 
Kanakis et al. 2011. The fluorescence spectra were obtained using λexc=280 nm and λemm 
from 290-500 nm and the intensity at 350nm (tryptophan (Trp)) was recorded. 
Preliminary fluorometry results showed that both β-LG and enzyme cocktails elicit very 
high fluorescent responses. After several tests, it was determined that responses of β-LG 
solutions with concentration between 0.2-0.4 µM were within instrument’s linear range 
of fluorescence. Literature on protein-polyphenol binding report protein:polyphenol 
ratios (P:P) of 10:1 down to 1:27 (Hasni et a. 2011, Kanakis et al. 2011, Soares et al. 
2007). Ratios ranging from 10:1 to 1:2 protein:polyphenol were tested keeping protein 
Sample Average Fluorescence 
Tris - HCl 135.1 “ 1.60 
Tris - HCl + EGCG 97.1 “ 1.05 
Tris - HCl + Enzymes 404.1 “ 2.06 





concentration constant (0.3 µM) and using EGCG as the model polyphenol, however the 
noise was bigger than the change in response, making it difficult to guage the relative 
extent of protein-polyphenol binding. Therefore, ratios ranging from 1:2 to 1:40 
protein:polyphenol were assayed, again keeping protein concentration constant (0.3 µM). 
For each subsequent decrease in milk protein:EGCG (MP:EGCG) at these levels, 
fluorescence decreased, indicating that mixtures containing the aforementioned 
MP:EGCG can be utilized to demonstrate the ability of EGCG to quench protein 
fluorescence. The objective of this assessment is to determine binding of EGCG to native 
and digested milk protein. Pepsin and pancreatin both contain Trp residues, thus the 
amount of fluorescence they contribute to total protein fluorescence in digesta was a 
concern. Therefore, 10-fold dilutions of enzyme cocktails containing pepsin and 
pancreatin were assayed, starting at concentrations used for in vitro digestion of green tea 
extract beverages (1.0 and 1.2 mg/mL, respectively), with and without β-LG. The 
fluorescent response of cocktails containing 0.01 and 0.012 mg/mL pepsin and pancreatin, 
respectively, was low in comparison to that of β-LG. The enzyme substrate ratio (E:S) 
used for in vitro digestion of green tea extract beverages in this study was about 2:1. 
Final digesta containing 0.5 µM milk protein and 0.01 mg/mL pepsin and 0.012 mg/mL 
pancreatin, for E:S ratio of 2:1 was used to obtain a clear fluorometric response from 
milk protein with little confounding fluorescence from digestive enzyme. According to 
literature, this E:S is sufficient for the digestion of B-LG (Mandalari et al. 2009, Otte et al. 
1997). Furthermore, a 12 µM solution of EGCG was prepared to be mixed 1:1 with 





and EGCG so that hypotheses concerning the effect of protein digestion on protein-
polyphenol interactions can be made. 
An EGCG stock solution (12 µM in Tris-HCl (10 mM, pH 7.4)) was prepared and 
kept on ice for analysis. EGCG was stable under these conditions with 98% recovery 
over 6 hr.  S-CSN and β-LG digested to various extents in vitro were mixed 1:1 with 
EGCG by inverting solution 10 times. EGCG and protein concentrations of each solution 
were about 6 and 0.25 µM, respectively. Pepsin and pancreatin were also present from 
background digestion enzyme mixes at 0.005 and 0.006 mg/mL, respectively, therefore, 
blanks containing milk protein and background digestive enzyme mix mixed 1:1 with 
Tris-HCl (pH 7.4) replacing EGCG (12 µM) were prepared. The fluorescence spectra 
were obtained using λexc=280 nm and λemi from 290-500 nm. The intensity at 350 nm 
(Trp) was recorded.  
 




Where: F0= initial fluorescence intensity (intensity of blank) 
F= fluorescence intensity in the presence of the quenching agent (intensity of 
protein-EGCG solution) 
 
The in vitro digestion procedure used prior to analysis by SDS-PAGE (outlined in 





preparation forfluorescence analysis.  S-CSN and β-LG solutions (0.023 g/L and 0.035 
g/L) were prepared in Tris-HCl (10 mM, adjusted with NaOH to pH 7.4). Final digesta 
were normalized to half starting protein concentration, 0.005 mg/mL pepsin, and 0.006 
mg/mL pancreatin and had final pH of 7.4. Gastric time zero (G0) samples were prepared 
by addition of 1mL pepsin solution (0.07 mg/mL in 0.1M HCl) and 1 mL pancreatin 
solution (0.084 mg/mL in 0.1 M NaHCO3) to 7 mL milk protein solution. G0 samples 
were made up to 14 mL with Tris-HCl, pH adjusted to 7.4, nitrogen gas and frozen (-
20°C). For remaining samples, protein solutions (7mL) were pH adjusted to 3.0±0.1 (by 
addition of 1 M HCl) and made up to 8 mL with saline. The gastric phase was initiated by 
addition of 1mL pepsin solution (0.07 mg/mL in 0.1 M HCl). Pancreatin (1 mL, 0.084 
mg/mL in 0.1 M NaHCO3) was added to gastric time zero (G0) samples which were then 
made up to 14 mL with Tris-HCl, pH adjusted to 7.4, and frozen (-20°C). The duodenal 
phase was initiated in remaining solutions by pH adjustment to 6.5±0.1 and addition of 
1mL pancreatin (0.084 mg/mL in 0.1 M NaHCO3). Samples representing completed 
gastric digestion (G1) were made up to 14 mL with Tris-HCl, pH adjusted to 7.4, and 
frozen (-20°C). The pH of remaining samples was readjusted to pH 6.5±0.1. The 
solutions were made up to 12 mL with saline, blanketed with nitrogen gas and incubated 
in a shaking water bath (85 opm, 37°C). Digestions were stopped at either 15, 30, 60, or 
120 mins (D15, D30, D60, D120), made up to 14 mL with Tris-HCl, pH adjusted to 7.4, 
and frozen (-20°C).   
The ability of select milk proteins to alter digestive stability and by extension 
bioaccessibility of flavan-3-ols led us to further investigate the nature of EGCG binding 





spectroscopy (Figure 11). EGCG was selected based on its abundance in tea and the high 
likelihood of its association with individual milk proteins (Poncet- Legrand 2007; Hasni 
et al. 2011; Baxter et al. 1997; Xiao et al. 2011; Xu & Chen 2011).  This method assessed 
the amount of Trp fluorescence quenched (%Fq) in individual protein by EGCG titration. 
Proteins (β-LG and S-CSN) were prepared in Tris-HCl, digested to various extents by 
pepsin and pancreatin at pH 3 and 6.5, respectively. The digesta were pH adjusted to 7.4 
before analysis by fluorometry and mixed with EGCG solutions (pH 7.4). Final solutions 
contained ~0.25 μM protein and ~6 μM EGCG. These levels were chosen based on 
preliminary experiments that showed favorable concentrations for interactions between 
milk protein/peptides and EGCG so that hypotheses concerning the effect of protein 
digestion on protein-polyphenol interactions could be made without confounding 
precipitation. 
%Fq by EGCG was greatest for both β-LG and S-CSN gastric digesta (G1), 
with %Fq of 13.23±0.90 and 12.39±1.06%, respectively (Figure 11). Furthermore, %Fq of 
β-LG G1 by EGCG was significantly greater (p<0.05) than quenching of undigested 
protein (6.67±0.65%) from each duodenal digesta. Specifically, %Fq of β-LG D15, D30, 
D60, and D120 were 6.86±1.02, 3.18±0.72, 4.78±0.75, and 5.83±1.85% respectively.  
However, %Fq of S-CSN G1 by EGCG was significantly greater (p<0.05) than only %Fq 
of S-CSN G0 (5.83±1.0%) and S-CSN D120 (5.12±1.07%). Interestingly, %Fq of 
undigested protein was not significantly different (p>0.05) for D15, D30, D60, and D120 
digesta for both proteins. Additionally, EGCG quenched more fluorescence from S-CSN 
peptides resulting from 15, 30, and 60 minutes of duodenal digestions compared to β-LG 





3.18±0.72, and 4.78±0.75%Fq, however this trend is not significant. Although %Fq of 
undigested protein and duodenal digesta were low compared to G1 digesta, it appears that 
some binding was still occurring.  
 
Figure C. 1: Percent Trp fluorescence quenched by EGCG of S-CSN digested to various 
extents. Digesta pH was adjusted to 7.4 and mixed 1:1 with Tris-HCl (pH 7.4) or EGCG 
(pH 7.4, 12 μM) for analysis by fluorescence spectroscopy. The lightest area of the graph 








Table C. 4: Percent Trp fluorescence quenched by EGCG of both β-LG and S-CSN 





G0 6.67 ± 0.65
G1 13.23 ± 0.90
D15 6.86 ± 1.02
D30 3.19 ± 0.72
D60 4.78 ± 0.75
D120 5.83 ± 1.85
Extent of 
Digestion %Fq
G0 5.83 ± 1.00
G1 12.39 ± 1.06
D15 9.84 ± 2.40
D30 5.79 ± 0.22
D60 8.15 ± 1.02






Table C. 3: Trp fluorescence intensity of S-CSN solutions with and without EGCG. 
Digesta pH and EGCG (12 μM) or Tris HCl were mixed 1:1 maintaining pH of digesta 
for analysis by fluorescence spectroscopy. Each line is one of four different digestion 
procedures: (1) S-CSN-EGCG binding effects due to digestive pH (gastric pH 3.0, 
duodenal pH 6.5) (2) extent of binding between EGCG and digestive enzymes and (3) 
combined effect of protein digestion, pH, and presence of enzymes in S-CSN digesta on 
fluorescence quenching of protein Trp residues by EGCG. Superscript star denotes 









- Quencher + Quencher
(1) S-CSN, no enzymes, 
pH 3 and 6.5
GpH0 393.01 ± 7.28 275.43 ± 1.47*
GpH1 398.16 ± 1.66 268.50 ± 2.79*
DpH15 451.73 ± 13.37 278.67 ± 24.97*
DpH30 420.10 ± 6.65 247.61 ± 8.30*
DpH60 429.60 ± 4.26 260.17 ± 7.97*
DpH120 405.12 ± 6.75 239.69 ± 2.91*
(2) Enzymes, 
pH 3 and 6.5
EG0 225.16 ± 11.98 182.13 ± 10.93*
EG1 222.77 ± 9.09 171.33 ± 6.35*
ED15 317.85 ± 23.49 280.12 ± 20.02*
ED30 298.61 ± 45.21 258.67 ± 40.62*
ED60 251.78 ± 12.24 207.01 ± 5.73*
ED120 243.32 ± 7.85 202.17 ± 6.29*
(3) S-CSN, enzymes, 
pH 3 and 6.5
FG0 463.12 ± 11.01 402.56 ± 13.35*
FG1 449.33 ± 5.36 374.37 ± 6.04*
FD15 598.30 ± 7.56 507.44 ± 11.33*
FD30 579.85 ± 6.21 499.61 ± 9.06*
FD60 559.94 ± 6.63 482.08 ± 10.46*





Table C.4: Percent Trp fluorescence quenched of S-CSN solutions by EGCG. Protein 
solutions and EGCG (12 μM) or Tris HCl were mixed 1:1 for analysis by fluorescence 
spectroscopy. Each line is one of four different procedures used to determine: (1) extent 
of binding between EGCG and digestive enzymes (2) S-CSN-EGCG binding effects due 
to digestive pH (gastric pH 3.0, duodenal pH 6.5) and (3) combined effect of protein 
digestion, pH, and presence of enzymes in S-CSN digesta on fluorescence quenching of 
protein Trp residues by EGCG. Different letters between treatments within a specific 
extent of digestion denotes significant difference (p<0.05). 
 
Extent of 
Digestion Treatment %Fq 
G0 
1 19.18  ± 1.10b 
2 29.83 ± 1.63a 
3 13.06  ± 2.36a 
G1 
1 23.01  ± 1.43b 
2 32.57 ± 0.48a 
3 16.69  ± 0.49a 
D15 
1 14.76  ± 1.57c 
2 42.61 ± 3.92b 
3 15.18  ± 1.60a 
D30 
1 13.56  ± 0.43c 
2 41.09 ± 1.39b 
3 13.85  ± 0.88a 
D60 
1 16.02  ± 0.84a 
2 39.45 ± 1.65b 
3 13.91  ± 1.41a 
D120 
1 16.96  ± 0.56a 
2 40.77 ± 1.50b 


















Appendix E: Specific Methodology 
 
Preparation of sodium caseinate 
 
Stock Solutions 
Acid precipitated casein 
Tris-HCl (10 mM, pH 7.4) 
1M NaOH  
 
Procedure: 
1. Prepare acid precipitated casein in Tris HCl 
2. Adjust pH to 6.3 using 1M NaOH solution 
3. Stir consistently for 2 hr using magnetic stir bar maintaining pH at 6.3 until 
powder is completely dissolved 
4. Store at 4°C for up to a week 




20 mg/mL pepsin in 0.1 M HCl 





Gastric Phase  
1. Place 14 mL tubes containing beverage (5.6 mL) on ice. 
2. Bring up to about 8.4 mL by addition of 0.9% saline. 
3. Adjust pH to 3.0 ± 0.1 using 1.0 M HCl. Record volume and pH. 
4. Add 0.56 mL of pepsin solution to each tube. 
5. Bring up to about 11 mL by addition of 0.9% saline. 
6. Collect and freeze (-20°C) samples representing gastric time zero. 
7. Blanket remaining samples with nitrogen gas, cap, parafilm. 
8. Incubate in shaking water bath at (37°C, 85 opm,1 hr) 
  
Intestinal Phase 
1. Remove tubes from water bath and place on ice. 
2. Freeze gastric digests representing 1 hour gastric digestion (-80°C) and freeze dry. 
3. Add 1.0 M NaHCO3 to raise pH to 6.5 ± 0.1. Record volume and pH. 
4. Add pancreatin solution (0.56 mL) to each tube. 
5. Check pH and readjust if needed. 
6. Bring up to 14 mL by addition of 0.9% saline. 
7. Blanket with nitrogen gas, cap, and parafilm. 













Tris-HCl (10 mM, pH 7.4) 
Bio-Rad 2x Laemmli buffer 
2% Coommassie Blue solution 
Destaining solution (30% methanol, 10% acetic acid, 60% dd H2O 
Molecular weight marker calibration kit 
 
Procedure: 
1. Resolubilize freeze-dried digest in Tris-HCl for about 8 mg/mL total test protein. 
2. Mix samples 1:1 with Bio-Rad 2x Laemmli buffer for 42 μL total solution and 
boil (5 minutes). 
3. Load samples (40 μL) to gel and molecular weight ladder (10 μL) onto gel. 
4. Run gel at 100V for about 1.5 hours. 
5. Stain gel with Coomassie Blue solution (30 min). 
6. Destain gel for 10 minutes in destain solution. Dispose of destain, and repeat 10 
minute destain a few times. Continue to destain overnight or until gel background 
is clear. 
 
In Vitro Digestion for Subsequent Fluorometric Analysis of Digesta 
 
Stock Solutions 
0.07 mg/mL pepsin in 0.1M HCl 
0.084 mg/mL pancreatin 
0.9% saline 





Gastric Phase  
1. Place 14 mL tubes containing beverage (7.0 mL) on ice. 
2. For gastric time 0 samples (G0):  
a. add pepsin solution (1 mL) and pancreatin solution (1 mL), bring up to 14 
mL total with Tris-HCl (pH 3.0), pH adjust to 3.0, and freeze (-20°C). 
3. For remaining samples:  
a. Adjust pH to 3.0 ± 0.1 using 1.0 M HCl (record volume and pH) . 
b. Bring beverage up to about 8 mL by addition of 0.9% saline. 





d. Blanket with nitrogen gas, cap, parafilm. 
e. Incubate in shaking water bath at (37°C, 85 opm, 1 hr) 
 
Intestinal Phase 
4. Remove tubes from water bath, place on ice 
5. For gastric time 1 hr samples (G1):  
a. Add pancreatin solution (1 mL), bring up to 14 mL total with Tris-HCl 
(pH 3.0), pH adjust to 3.0, and freeze (-20°C). 
6. For remaining samples: 
a. Add 1.0 M NaHCO3 to raise pH to 6.5 ± 0.1 (record volume and pH). 
b. Add pancreatin solution (1 mL) to each tube. 
c. Check pH, and readjust if needed. 
d. Bring up to 12 mL by addition of 0.9% saline. 
e. Blanket with nitrogen gas, cap, and parafilm. 
f. Incubate in shaking water bath at (37°C, 85 opm,≤2 hr). 
g. Bring samples representing various extents of duodenal digestion to 14 
mL with Tris-HCl pH 6.5, pH adjust to 6.5 if needed, and freeze (-20°C)  
 
 
Fluorometric Analysis  
 
Instrument: Perkin-Elmer LS55 Spectrometer 
Excitation wavelength: 280nm 
Emmission wavelength: 290-500 
Wavelength of interest (Trp): 350nm 
 
Procedure: 
1. Pipette sample and with either Tris-HCl or quencher into cuvette 1:1 
2. Invert solution ten times 
3. Wipe down cuvette with Kim Wipe 
4. Place in fluorometer 
5. Record fluorescence 
 
 
 
 
 
